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Mammalian females form their germ cells (oocytes) before or shortly after 
birth. The oocytes interact with somatic cells to form primordial follicles, creating 
the quiescent population from which oocytes will be recruited to grow throughout 
life. A female’s fertility life span is therefore, dependant on the size of this pool and 
the rate at which primordial follicle are activated to grow. However, there is still 
much we do not know about the quiescent follicle population and the mechanisms 
that control their recruitment into the growing follicle population are still unclear. 
There is evidence that the phosphoinositide-3-kinase (PI3K) pathway is key to 
activation of follicle growth. The role of the PI3K pathway has been primarily 
explored in the rodent model and has highlighted this pathway’s importance both in 
the activation of quiescent follicle growth and maintaining dormancy of the quiescent 
follicle population. This thesis aimed to explore if the PI3K pathway played a similar 
role in a large mono-ovulatory species as it does in the small polyovulatory rodent 
species. 
Bovine is a mono-ovulate species, which has similar attributes in its 
reproduction and folliculogenesis to the human in vivo; therefore using an in vitro 
bovine model might be a valuable indication of the role of the PI3K pathway in the 
human. Initial experiments tested if the bovine was a good model for human 
primordial follicle activation in an in vitro environment. It was observed that the 
bovine and human had comparative levels of activation and subsequent increases in 
both the primary and secondary follicle populations within an in vitro culture system. 
These similarities indicate that the bovine is a relevant model for the human in vitro. 
It is not possible to culture the entire bovine ovary. Therefore knowing the 
location of the primordial follicles is important to establishing what region(s) of the 
ovary to use. The overall concentration of ovarian follicles was higher in the cortex 
and gradually declined through the consecutive inner layers of the ovary. The 
distribution of the ovarian follicle populations were different in each distinctive 
region of the ovary with the quiescent follicles representing a much larger proportion 
of the ovarian follicle population in the cortex compared to the inner regions of the 
ovary. The location an ovarian follicle in the ovary was seen to influence its health in 
both the quiescent and growing follicle populations, with reduced health seen in the 
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inner layers of the ovary compared to the cortex. This resulted in very few healthy 
quiescent follicles outside of the cortex region making it the more favourable region 
to culture in functional studies. 
The role of the PI3K pathway was therefore explored using an in vitro bovine 
model using the pharmacological compounds bpV (HOpic) and 740Y-P, both of 
which caused an up-regulation of the PI3K-pathway. It was observed that up-
regulation of the PI3K pathway caused an increase in the activation of the quiescent 
follicle population, and the resulting primary follicles were larger in size. However, 
there was reduced health in both the growing and quiescent follicle populations. The 
ill health appears to be due to a disruption in the co-ordination of growth between 
oocyte and granulosa cells in the ovarian follicles, leading to enlarged oocytes in 
both the primary follicles and quiescent follicles. Although the PI3K pathway caused 
an increase in quiescent follicle activation and larger primary follicles there was no 
increase in the number of viable large secondary follicles obtained. The growth of 
the secondary follicles was unaltered by the initial activation of the quiescent 
follicles via the PI3K pathway. These experiments show that the PI3K pathway plays 
a role in primordial follicle activation in large mono-ovulate species. However, up-
regulating the PI3K pathway results in a decrease in health of the quiescent and 
primary follicle populations, thus limiting its immediate value as a therapeutic target. 
This study has improved our understanding of the role of the PI3K pathway 
in primordial follicle activation in a large mono-ovulate species.  It has highlighted 
that the up-regulation of the PI3K pathway using both bpV (HOpic) and 740Y-P 
increases the activation of the bovine ovarian follicles in vitro. However, up-
regulating the PI3K pathway disrupts the development of the ovarian follicles 
resulting in retarded growth and thereby a decrease in the survival of both the 
quiescent and growing follicle populations. The similarities in activation, growth and 
development between the bovine and the human in vitro indicate that the results 
observed in the bovine are a good indication of what would occur in the human. This 
study has also improved our understanding of the location, distribution and viability 
of the ovarian follicle population within the ovary. 
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1.1 General Background 
 
The mammalian ovary is the central organ within the female reproductive 
system. It has a number of key roles including the production of sex steroid 
hormones that regulate the development of secondary sex characteristics, and 
preparing the uterus and fallopian tubes for fertilisation and pregnancy. In addition to 
its role as an endocrine organ the ovary contains the supply of female germ cells 
(oocytes) contained within ovarian follicles. In the mammalian ovary the store of 
oocytes are held in a dormant state in primordial follicles, these oocytes are arrested 
at the diplotene stage of the first meiotic prophase and are considered to be immature 
as at this stage they can not be fertilised (Escobar et al., 2011; McGee and Hsueh, 
2000, Telfer, 1998). In order for a mature oocyte to be produced the primordial 
follicles must undergo folliculogenesis. Folliculogenesis is the progression of the 
primordial follicles to growth and develop to become primary, preantral (secondary), 
antral and eventually pre-ovulatory follicles. Progression through the different 
developmental stages by the ovarian follicle allows its oocyte to grow and develop 
enabling it to reach a stage where the oocyte can resume meiosis, at this point the 
oocyte is considered to be mature as it possible for the oocyte to be fertilised. 
Ovarian follicles undergoing folliculogenesis make up the growing follicle 
population in the ovary (Binelli and Murphy, 2010; McGee and Hsueh, 2000). 
 
1.2 Structure of the Ovary 
 
The structure of the ovary varies widely between different species. However, 
within most mammalian species it is possible to identify three distinct structures in 
the ovary; surface epithelium, cortex and medulla. The surface epithelium is the 
outer most layer of the ovary and is made of a single layer of cuboidal cells. The 
medulla region is found in the centre of the ovary and is formed from loosely 
connected connective tissue and is highly vascularised (Escobar et al., 2011). 
Between the surface epithelium and medulla lies the cortex comprising of stromal 
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tissue formed from tightly compact connective tissue and is a poorly vascularised 
region. 
The ovarian follicle population is not evenly distributed in the ovary since around 
90% of the entire store of ovarian follicles, at all stages of their development, are 
located in the cortex (Escobar et al., 2011; vanWezel and Rodgers, 1996). In the 
cortex the ovarian follicle population is concentrated at the outer cortex and 
gradually declines through the consecutive layers of the ovary from the inner cortex 
to the cortex-medulla border and finally to the medulla itself. The location of the 
ovarian follicles appears to be influenced by their developmental stage, with 
primordial follicles predominately found in the outer cortex, whereas, growing 
follicles are mainly found in the inner cortex and the cortex-medulla border (Jimenez, 
2010; vanWezel and Rodgers, 1996) (see figure 1.1).  
 
 
Figure 1.1: Structure of the Ovary. The ovary consists of the a) surface 
epithelium at the outer edge of the ovary. The next layer into the ovary is b) cortex 
and then at the center is c) medulla. Here it is possible to see that d) smaller non-
growing follicles are found pre-dominantly in the outer regions of the cortex and e) 
growing follicles are found mainly in the inner cortex and at the cortex-medulla 
border.  
 
In current clinical practice for fertility preservation (von Wolff et al., 2009) and 
in vitro research examining primordial follicles (Braw-Tal and Yossefi, 1997; 
McLaughlin and Telfer, 2010; Telfer et al., 2008; Wandji et al., 1996a; Wandji et al., 
1997) in species where culturing the whole ovary is not possible due to its large size 
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(Telfer et al., 2000; Thomas et al., 2003; Wandji et al., 1996b) only the cortex is 
utilised as this is where the primordial follicles are predominately thought to be 
located. However, a recent study by Kristensen et al., 2011 in the human observed 
that the medulla did not only contain a population of growing follicles but also 
contained a population of primordial follicles (Kristensen et al., 2011). This, 
therefore, raises the question that by only using the cortex are we losing a potential 
source of primordial follicles in the discarded medulla? This thesis aimed to better 
understand the primordial follicle population. Therefore, it is important to understand 
their location in the ovary and so this thesis aimed to explore the location of the 
ovarian follicles in the ovary and examine if their location in the ovary had any 
influence on the distribution of non-growing and growing ovarian follicles and their 
viability.  
 
1.3 Formation of the Primordial Follicle Pool 
 
In the mammalian ovary the formation of oocytes begins during fetal life; they 
are derived from a population of cells called primordial germ cells (PGCs). The 
PGCs are formed in early embryogenesis in the embryonic hindgut in the proximal 
epiblast and must migrate to colonise the gonadal ridges (early gonads), which are 
located alongside the ventral side of the mesonephros (Molyneaux et al., 2001; 
Pepling and Spradling, 2001). During this migration through the fetus the PGCs are 
continuously and rapidly dividing by mitosis. This rapid proliferation means that 
there is much great number of cells being produced than lost through cell death, 
allowing the PGCs to reach their species-specific number (Ginsburg et al., 1990; 
McLaren, 2003; Tam and Snow, 1981). This species-specific number is thought to 
ensure the required number of primordial follicles is produced later to ensure a 
normal reproductive lifespan. The proliferation and survival of the PGCs is under the 
regulation of a number of different factors, for example; cAMP-mediate mechanisms 
(De Felici et al., 1993; Dolci et al., 1993), pituitary adenylate cyclase-activating 
polypeptide (Pesce et al., 1996) and growth factors including stem cell factor (SCF), 
leukemia inhibitory factor (LIF), fibroblast growth factor (FGF) and kit ligand (KL) 
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(De Felici and Dolci, 1991; Cheng et al., 1994; Godin et al., 1991; Matasui et al., 
1991; Kawase et al., 2004; Takeuchi et al., 2005). 
PGCs undergoing mitotic divisions in the ovary are now known as oogonia. 
Cytokinesis is incomplete during these divisions, which results in the oogonia still 
being connect by cytoplasmic bridges thereby, causing them to be clustered together 
to form nests (or germ cell cysts) in the developing ovary (Anderson et al., 2008; 
Greenbaum et al., 2011; Molyneaux et al., 2001; Pepling and Spradling, 1998; 
Pepling and Spradling, 2001). Eventually, the oogonia will stop dividing by mitosis 
and begin to enter meiosis to become primary oocytes (De Felici et al., 2009). 
Meiosis in the primary oocytes is arrested at the diplotene stage of meiotic prophase I 
(Telfer, 1998). If the oocyte is to survive it must form associations with somatic cells 
(pre-granulosa cells) to form a structure known as a primordial follicle (Pepling, 
2012; Pepling and Spradling, 2001).  
Primordial follicles represent the pool of germ cells that must last a female 
throughout her reproductive life. It is widely accepted that this pool is the only 
source of fertilisable oocytes produced, with no additional primordial follicles being 
created at any other point in a female’s life (McGee and Hsueh, 2000; Zuckerman, 
1951). However, this dogma has recently been challenged by the discovery of 
germline stem cells within the adult mouse and human ovary which could have the 
potential to replenish the primordial follicle pool (Johnson et al., 2004; White et al., 
2012; Zou et al., 2009). Nonetheless, further investigation is required to better 
understand the role of the germline stem cells in the ovary and the reproductive 
lifespan. 
 
1.4  Primordial Follicle Fate 
 
Once the pool of primordial follicles has been established the primordial follicles 
have three distinct fates; dormancy, activation or death. Primordial follicles are able 
to remain healthily in a dormant state for years or decades depending on the species. 
However, each primordial follicle will eventually either be activated to undergo 
folliculogenesis or be lost directly from the primordial follicle pool through 
programmed cell death processes known as atresia (Broekmans et al., 2007; Hansen 
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et al., 2008; McGee and Hsueh, 2000). Activation is irreversible, therefore, once a 
primordial follicle is activated it must continue through the various stages of 
folliculogenesis or it will undergo atresia (Elvin and Matzuk, 1998). Controlling the 
number of primordial follicles that are activated or lost from the primordial follicle 
pool is therefore, key to maintaining a healthy reproductive lifespan. If either 
activation or loss occurs at too rapid a rate the primordial follicle pool will be 
exhausted faster and the individual will undergo premature ovarian failure (POF).  
 
1.4.1 Mechanisms Involved in the Control of Primordial Follicle Fate  
 
The mechanisms involved in primordial follicle activation and loss are still 
unclear although recently a number of different studies have highlighted a range of 
factors that appear to play a role in both activation and maintaining the dormancy of 
the primordial follicle population. The evidence for these mechanisms being 
involved in primordial follicle activation has predominately been discovered through 
the use of rodent models, so the next section will focus on what has been found using 
these models (Adhikari et al., 2013; Cecconi et al., 2004; Kim, 2012; Monget et al., 
2012; Pangas, 2012; Reddy et al., 2010). 
 
1.4.1.1 Phosphoinositide-3-kinase (PI3K) Pathway 
 
1.4.1.1.1 The Mechanisms of the PI3K Pathway 
 
The PI3K pathway is known to play an important role in cellular survival, growth 
and proliferation through a variety of downstream mechanisms (Cantley, 2002; 
Stokoe, 2005). It is stimulated through extracellular signalling by a range of factors, 
such as growth factors and hormones, binding to the receptor protein tyrosine kinases 
(RPTK) (see figure 1.2). This stimulates RPTK to autophosphorylate itself enabling 
it to bind to PI3K (Cantley, 2002; Simpson and Parsons, 2001; Stokoe, 2005). PI3K 
is a heterodimer consisting of a regulatory and a catalytic subunit. The regulatory 
unit (p85) acts to maintain the catalytic subunit (p110) in a low-activate state. 
Autophosophorylated RPTK binds to the Src homology (SH2) domain of the p85 
subunit thereby, preventing p85 from inhibiting the p110 subunit. p110, now in a 
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high activated state, can phosphorylate phosphatidylinositol-4,5-biphosphate (PIP2) 
to become phosphatidylinositol-3,4,5-triphosphate (PIP3). The amount of PIP3 
produced is regulated by phosphatase and tensin homolog (PTEN), which acts as a 
negative regulator to prevent this pathway becoming too up-regulated by 
dephosphorylating PIP3 back to PIP2. While PIP3 exists it can co-bind with 3’-
phosphionositide-dependent kinase 1 (PDK1) to activate downstream components 
including; protein kinase B (PKB) better known as Akt and ribosomal protein S6 
kinase (rpS6), which mediate various downstream components, such as forkhead box 
03a (Foxo3a) and p27, to promote cell cycle progression, cellular growth and 
proliferation (Blume-Jensen and Hunter, 2001; Brunet et al., 2001; Cantley, 2002; 
Engelman et al., 2006; Stokoe, 2005; Vanderhyden, 2002). 
 
 
Figure 1.2: The PI3K Pathway. Stimulation of RPTK causes the activation of 
PI3K, which phosphorylates PIP2 to become PIP3. PIP3 then co- binds with PDK1 
to activate Akt by phosphorylation. The level of PIP3 is control by PTEN, which 
dephosphorylates PIP3 back into PIP2. Activated Akt phosphorylates Foxo3a and 
p27 causing them to be moved out of the nucleus and preventing them from 
inhibiting cell cycle progression. Akt also phosphorylates S6K1, which leads to 
protein translation via rpS6, enabling cell proliferation to occur. 
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1.4.1.1.2 The Role of the PI3K pathway in Primordial Follicle Activation 
and Dormancy. 
 
The role of the PI3K pathway in primordial follicle activation has been displayed 
predominately through knockout mouse models, which have targeted a number of 
key aspects of the pathway. The up-regulation of the PI3K pathway was explored 
using three knockout rodent models; PTEN knockout (Reddy et al., 2008), Foxo3 
knockout (John et al. 2008, Castrillon et al 2003) and p27 knockout (Rajareddy, 
Reddy et al. 2007). PTEN (Reddy et al., 2008) negatively regulates the PI3K 
pathway by converting PIP3 back into PIP2 (Cantley, 2002). Foxo3a is part of a 
family of forkhead transcription factors that mediate apoptosis and cell cycle arrest 
through the PI3K pathway (Accili and Arden, 2004; Arden and Biggs, 2002; Brunet 
et al., 1999). Lastly, p27 is a cyclin-dependent kinase (cdk) inhibitor. cdk encourages 
the transition between the cell cycle stages therefore, p27 inhibits this to negatively 
regulate the cell cycle and cellular growth (Fero et al., 1996; Kaldis, 2007). Foxo3a 
and p27 are both only in their active state in the nucleus. Both Foxo3a (Accili and 
Arden, 2004; Arden and Biggs, 2002; Liu et al., 2007) and p27 (Fero et al., 1996; 
Rajareddy et al., 2007; Zhang et al., 1999) are located in the nucleus of the 
primordial follicles, whereas, the nuclei of growing follicles have no Foxo3a and the 
levels of p27 are increasingly reduced as the ovarian follicles progress further 
through folliculogenesis.  
Within these three models the up regulation of the PI3K pathway did not appear 
to impact primordial follicle formation, as there was no change in the morphology or 
number of ovarian follicles compared to the control mice. However, in all of them 
there was a change in the rate of primordial follicle activation (Castrillon et al., 2003; 
John et al., 2008; Liu et al., 2007; Rajareddy et al., 2007; Reddy et al., 2008). At 
postnatal day (PD) 8 in oocyte-specific PTEN deficient mice the ovaries appeared to 
be larger in size and only 49.6% of the ovarian follicles were primordial compared to 
83.6% in the control mice. By PD23 there were no primordial follicles left in the 
PTEN deficient mice, whereas, 69.2% of the ovarian follicles were still primordial in 
the control mice (Reddy et al., 2008). Similarly, the morphology of the ovaries of 
Foxo3a deficient mice indicates that the primordial follicles were recruited into the 
growing follicular pool at a faster rate, causing an increased rate of depletion in the 
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pool of primordial follicles (John et al. 2008, Castrillon et al 2003). Likewise, p27 
deficient mice were seen to have an increase in activation, which resulted in almost 
all the primordial follicles being activated by the time these mice reached puberty 
(Rajareddy, Reddy et al. 2007). This up regulation of the PI3K pathway and 
subsequent increase in primordial follicle activation resulted in the mice becoming 
infertile at an early age. This is observed in the PTEN deficient mice having only one 
litter in 6-34 weeks (John et al., 2008; Reddy et al., 2008) and Foxo3a deficient mice 
only produced 2 litters (John et al., 2008). 
The down regulation the PI3K pathway has also been explored by using 
knockout mouse models of; PDK1, rpS6 (Reddy et al., 2009), and a mouse model 
which ensured Foxo3a was constantly active (Liu et al., 2007). PDK1 is required to 
co-bind with PIP3 to activate Akt and thereby activating the downstream 
components of the PI3K pathway (Engelman et al., 2006; Mora et al., 2004). rpS6 is 
a downstream component of the PI3K pathway that is activated by S6K1 to promote 
protein translation (Volarevic et al., 2000). Lastly, Foxo3a, as mention above, is in 
its active state in the nuclei, where it mediates apoptosis and cell cycle arrest (Accili 
and Arden, 2004; Arden and Biggs, 2002; Brunet et al., 1999).  
Primordial follicle formation was not impacted by a down regulation of the PI3K 
pathway, as none of the models show any differences in morphology or number of 
ovarian follicles compared to the control mice (Liu et al., 2007; Reddy et al., 2009). 
In the PDK1 deficient mice the pool of primordial follicles was unaltered in early life 
between PD8 and PD23. However, by the time the mice reached sexual maturity at 
PD35 the PDK1 deficient mice had only 33.7% of the number of primordial follicles 
seen in the control ovary. There was also a decrease in the number of activated 
follicles so there was only 61.6% of the proportion of growing follicles observed in 
the control mice. The reduction in the number of primordial and growing follicles is 
thought to be the reason that ovaries of the PDK1 mice are smaller in size. The 
primordial follicles were largely unhealthy in the PDK1 deficient mice with only 
27.7% of the number of healthy follicles observed in the control ovaries (Reddy et al., 
2009). Similarly, the rpS6 deficient mice had smaller ovaries and a dramatic 
reduction in the number of ovarian follicles by PD23. At PD35 there was a decrease 
in the health of both the primordial and growing follicles. By week 8 the follicle 
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structures had completely disappeared in the ovaries (Reddy et al., 2009). In the 
ovaries where Foxo3a was constantly activated there was a reduction in the number 
of secondary follicles and further developed ovarian follicles at both PD8 and PD13. 
At PD24, while wild type ovaries showed signs of ovulation, the Foxo3a activated 
ovaries had very few ovarian follicles reaching the later stages of follicular 
development and there was no evidence of ovulation having occurred (Liu et al., 
2007). Both the PDK1 and rpS6 knockout mice were infertile (Reddy et al., 2009), 
with the primordial follicle pool being completely exhausted by 8 weeks of age in the 
PDK1 deficient mice (Reddy et al., 2009). In the constantly activated Foxo3a mouse 
model there was a dramatic reduction in fertility, as in a 6 month period only 0.3 
pups were born on average per pair compared to an average of 47.4 pups per control 
pair (Liu et al., 2007).  
Activation and growth of ovarian follicles is co-ordinated through the bi-
directional communication between the oocyte and its granulosa cells (Albertini and 
Barrett, 2003; Elvin and Matzuk, 1998; Eppig, 2001). Interestingly, only the PTEN 
oocyte-specific knockout model caused an increase in primordial follicle activation 
(Reddy et al., 2008), whereas the PTEN specific deletion in the granulosa cells had 
no impact on follicle activation or dormancy (Fan et al., 2008). This, therefore, 
indicates that role of the PI3K pathway in the activation of the primordial follicles is 
controlled by the oocyte rather than the granulosa cells. This agrees with the 
hypothesis that it is the oocyte that has the intrinsic follicular developmental program 
(Eppig, 2001; Eppig et al., 2002), although further studies are required to better 
understand the role of both the oocyte and granulosa in primordial follicle activation. 
These rodent studies therefore, show that the PI3K pathway is important for both 
the activation of primordial follicles and maintaining the dormancy of the primordial 
follicle pool. The up regulation of the PI3K pathway caused an increased rate of 
primordial follicle activation, whereas down regulating the PI3K pathways resulted 
in the primordial follicles being lost directly from the primordial follicle pool. Both 
resulted in premature exhaustion of the primordial follicle pool, therefore, balancing 
the level of PI3K pathway signalling is essential to maintain a normal healthy 
reproductive lifespan.  
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1.4.1.1.3 Pharmacological Compounds Used to Explore the Role of the 
PI3K Pathway.  
 
Two pharmacological compounds bpV (HOpic) (EMO Chemical Inc., San Diego, 
U.S.A) and 740 Y-P (TOCRIS Bioscience, Bristol, UK) have been shown up 
regulate the PI3K pathway. bpV (HOpic) is a bisperoxovanadium (bpV) compound 
that inhibits protein tyrosine phosphatases, and is selective to PTEN. bpV (HOpic) 
binds to PTEN inhibiting its ability to convert PIP3 back into PIP2 (see figure 1.3) 
(Bevan et al., 1995; Li et al., 2010; McLaughlin et al., 2014; Posner et al., 1994; 
Schmidt et al., 2004). 740 Y-P is a phosphopeptide activator of PI3K. 740Y-P binds 
to the SH2 domain of the p85 regulatory subunit of PI3K to preventing p85 from 
inhibiting p110 and therefore, stimulating the activity of p110 (Derossi et al., 1998; 
Li et al., 2010).  
740 Y-P and bpV (HOpic) cause a similar increase in primordial activation in the 
mouse model (Li et al., 2010) to the knockout mouse models in previous studies 
where PI3K pathway was up regulated (Castrillon et al., 2003; John et al., 2008; Liu 
et al., 2007; Rajareddy et al., 2007; Reddy et al., 2009; Reddy et al., 2008). These 
pharmacological compounds have allowed the role of the PI3K pathway to be 
explored in the human using bpV (HOpic) (Li et al., 2010; McLaughlin et al., 2014); 
these studies demonstrated an increase in primordial follicle activation but resulted in 
a decrease in follicle survival. Recently, a live human birth has been reported using 
bpV (HOpic) and 740 Y-P followed by replacement and IVF (Kawamura et al., 
2013). In this study ovaries of 27 primary ovarian insufficiency (POI) patients were 
dissected into strips and exposed to bpV (HOpic) and 740 Y-P before being 
autotransplanted beneath the serosa of the Fallopian tubes. The patients were 
monitored and in 8 of the patients follicle growth was observed and at the antral 
stage (>5mm) of development the patients were treated with daily doses of FSH. 
When the follicles reached a size >16mm the patients were injected with hCG and 36 
hours later the egg was retrieved. Mature oocytes were retrieved successfully from 5 
of the patients and underwent intracytoplasmic sperm injection and when the 
embryos reached the four-cell stage they were cryopreserved so that they could be 
transferred back into the patient at a later date. The patient who went on to give birth 
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following this treatment at the age of 29 had experienced irregular cycles at the age 
of 23 and at 25 had become amenhorreic, with her levels of FSH seen to be elevated, 
however, no specific cause was found. This study suggests that stimulating Akt could 
be a new method to improve current fertility treatments. However, it is hard to 
determine the role of the PI3K pathway as this study did not have a control and the 
ovary being dissected and the steroid treatments would have impacted other 
pathways as well as PI3K. Therefore it is important to expand our knowledge of the 
role of the PI3K pathway, particular within the large mono-ovulatory species, which 
this thesis aimed to do. 
 
 
Figure 1.3: Interactions of the pharmacological compounds bpV (HOpic) 
and 740 Y-P with the PI3K pathway. bpV (HOpic) inhibits PTEN preventing it 
from converting PIP3 back into PIP2. 740 Y-P binds to the p85 subunit of PI3 kinase 
preventing it from inhibiting p110, resulting in increased catalytic activity of p110. 
Both cause the up regulation of the PI3K pathway resulting in increased levels of 








1.4.1.2 mTOR Pathway 
 
1.4.1.2.1 mTORC1 Pathway Mechanisms 
 
Mammalian target of rapamycin (mTOR) is associated with two distinct 
complexes known as mammalian target of rapamycin complex 1 (mTORC1) and 
mammalian target of rapamycin complex 2 (mTORC2) (Jacinto et al., 2004; 
Sarbassov et al., 2004). mTORC1 is known to promote cellular proliferation and 
growth by activating S6K1, thereby, inactivating eukaryotic translation initiation 
factors (Fingar and Blenis, 2004; Wullschleger et al., 2006). S6K1 is also responsible 
for the activation of rpS6 via phosphorylation, which increases protein translation 
and ribosomal biogenesis (Wullschleger et al., 2006). mTORC1 is negatively 
regulated by the tuberlin/tuberous sclerosis (Tsc) complex, Tsc1-Tsc2, through the 
GTPase activating protein domain of Tsc2. The role of Tsc1 is to prevent the 
ubiquitination and degradation of Tsc2 (Chong-Kopera et al., 2006). 
 
 1.4.1.2.2 Role of the mTORC1 Pathway in Primordial Follicle Fate 
 
The mTORC1 pathway has been shown to be involved in primordial follicle 
activation through knockout mouse models, that targeted Tsc1 (Adhikari et al., 2010) 
and Tsc2 (Adhikari et al., 2009) of the Tsc complex. In both Tsc1 and Tsc2 oocyte-
deficient mice there was an increase in mTORC1 activity and consequently its 
downstream components S6K1 and rpS6, showing that their deletion resulted in an 
up regulation of Tsc-mTORC1-p70S6 signalling.  
The deletion of both Tsc1 and Tsc2 led to a shortened reproductive life in mice, 
which produced only two normal sized litters before becoming infertile in early 
adulthood. The formation of ovarian follicles was unchanged by the deletion of either 
Tsc1 or Tsc2 as both displayed no difference in either morphology or number of 
primordial follicles compared to wild type mice. By PD23 both Tsc1 and Tsc2 
deficient mice were seen to have enlarged ovaries, and it was observed that all of the 
primordial follicles had been activated whereas, 74% of the ovarian follicles were 
still primordial in the controls (Adhikari et al., 2009; Adhikari et al., 2010). By 2 
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months the majority of ovarian follicles had become atretic, resulting in a reduced 
number of ovarian follicles (Adhikari et al., 2010). The primordial follicle pool was 
completely depleted in the Tsc1 and Tsc2 deficient mice by 3 (Adhikari et al., 2010) 
and 4 months (Adhikari et al., 2009) respectively, and no healthy follicular structures 
were found within the ovary.  
Therefore, mTORC1 activity plays an important role in the activation of the 
primordial follicles and its level of signalling must be controlled to prevent POF. In 
the human the mTOR pathway was also shown to be important in maintaining the 
primordial follicles in their dormant state as when this pathway was down regulated, 
using the mTOR inhibitor rapamycin, there was a loss of ovarian follicles and a 
decrease in ovarian follicle health (McLaughlin et al., 2011). This indicates that 
mTOR is involved in controlling primordial follicle fate by regulating both their 
activation and maintaining their dormancy.  
 
1.4.1.3 Interactions of the PI3K Pathway and mTOR Pathway  
 
Activation of primordial follicles is dependent on both PI3K and mTOR 
signalling (Adhikari et al., 2009; Adhikari et al., 2010; Reddy et al., 2008). Although 
mTOR is not strictly part of the PI3K pathway it is closely related (Guertin and 
Sabatini, 2007; Wullschleger et al., 2006), as S6K1 is a down stream component of 
both signalling pathways. For S6K1 to become active it must be phosphorylated by 
Tsc/mTOR-p70S6 signalling at threonine (T)389 and by PI3K –Akt signalling at 
T229 (see figure 1.4).  
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Figure 1.4: The PI3K Pathway and mTOR Pathway. The PI3K pathway and 
mTOR pathway are seen to converge at S6K1 as this component must be 
phosphorylated by both to stimulate the downstream components further on. 
 
The pathways were shown to be independent from each other as an increase in 
PI3K signalling did not cause an increase in mTOR signalling (Reddy et al., 2008), 
and likewise, increased mTOR activity did not increase PI3K signalling. To 
understand the interaction between these two pathways mice deficient in both PTEN 
and Tsc1 were compared to mice deficient in just PTEN or Tsc1. At PD23 mice 
deficient in both Tsc1 and PTEN had significantly more primordial follicles activated 
compared to either mice with just a PTEN or Tsc1 deficiency (Adhikari et al., 2010). 
The interactions of PI3K and mTORC1 signalling were also examined using PTEN 
deficient mice in combination with the mTOR inhibitor rapamycin (Adhikari et al., 
2013). At P23 there was a decrease in the size of the PTEN deficient ovaries treated 
with rapamycin in comparison to the untreated PTEN deficient ovaries. There were 
also significantly more primordial follicles in the PTEN deficient ovaries treated with 
rapamycin compared to the untreated PTEN deficient mice where almost the entire 
follicular pool had been activated. However, although rapamycin prevented all of the 
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primordial follicles being activated, only 20% of the ovarian follicles were 
primordial in comparison to 70% in the control (Adhikari et al., 2013). This indicates 
that mTORC1 and PI3K signalling influence one another but are able to activate 
primordial follicles independently. 
 
1.4.2 The Role of RTPK Stimulation by Growth Factors in Primordial 
Follicle Activation. 
 
There are a number of different growth factors which act via RPTK that have 
been highlighted to play a role in primordial follicle activation, including neutrophins, 
insulin, basic fibroblast growth factor (bFGF), keratinocyte growth factor (KGF) and 
platelet-derived growth factor (PDGF). The role of neutrophins was assessed through 
a knockout mouse model whereas; the others were assessed by exposure to varying 
concentrations of each growth factor.  
Neutrophins are usually associated with the differentiation and survival of the 
neuronal population in the central and peripheral nervous system (Snider, 1994). 
They have also been indicated to play a role in the ovary due to their presence and 
the presence of their receptors (Ojeda et al., 2000) in both the oocyte and the 
granulosa cells (Dissen et al., 2001). An example of their role is observed in the 
nerve growth factor (NGF) knock out mouse model. At PD7 the NGF deficient mice 
had less primary and secondary follicles compared to the control where follicles at 
these stages were more abundant (Dissen et al., 2001). Similarly, ovaries treated with 
glial-derived neurotrophic factor (GDNF) had an increased number of growing 
follicles at day 4 with 54.3% of the ovarian follicles activated to grow in comparison 
to only 41.3% in the control (Dole et al., 2008).  
Similarly, insulin receptors are found predominately in the oocyte of primordial 
follicles (Samoto et al., 1993). A study by Kezele et al 2002 treated mice with 
different doses of insulin, and observed an increase in the number of primordial 
follicles activated. At the highest dose around 30% more primordial follicles had 
been activated to begin folliculogenesis (Kezele et al., 2002).  
Likewise, bFGF is found in the oocytes of both primordial and primary follicles 
(van Wezel et al., 1995; Yamamoto et al., 1997). Ovaries treated with bFGF showed 
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an increase in primordial follicle activation; 40% of the ovarian follicles were 
primordial and 60% growing follicles in the control ovaries, in the bFGF treated 
ovaries only 15% of the ovarian follicles were primordial and 85% were growing 
follicles (Nilsson et al., 2001; Nilsson and Skinner, 2004). Activation via bFGF has 
also been observed in the human (Wang et al., 2014).  
KGF is a prototypical mesenchymal factor (Rubin et al., 1995), which helps 
promote the transition of the primordial follicles into primary follicles. Rat ovarian 
cultures treated with KGF showed 65% of primordial follicles had been activated in 
comparison to the control where only 45% of primordial follicles had been activated. 
KGF exposure to the rat ovaries caused an increase in KitL mRNA expression and 
KitL exposure to the rat ovaries caused an increase in expression of KGF mRNA 
(Kezele et al., 2005). It is though that this is because the KGF, produced by the theca 
cells (Parrott et al., 1994), causes the granulosa cells to promote their KitL 
expression and, in a positive feed back loop, stimulates the theca cells (Parrott and 
Skinner, 1998).  
Lastly, PDGF stimulation leads to numerous cellular responses involved in 
proliferation, survival and chemotaxis (Heldin et al., 1998). The PDGF protein is 
found within both the oocytes of the primordial and primary follicles and seen to be 
higher in the developing follicles. Treatment with PDGF causes a significant increase 
in the activation of the primordial follicles whereas, treatment with anti-PDGF 
neutralising antibody caused a significant decrease in primordial follicle activation 
(Nilsson et al., 2006).  
 In summary, stimulation of RTPK by growth factors such as neutrophins, 
insulin, bFGF, KGF and PDGF plays a role in primordial follicle activation. An 
increase in the stimulation of the RTPK, caused by increasing the levels of these 
factors, resulted in increased primordial follicle activation. When the stimulation is 









FoxL2 is a single gene belonging to a family of winged-helix/forkhead 
transcription factors (Crisponi et al., 2001). In humans mutations in FoxL2 led to 
truncation and it is likely the individual will undergo premature ovarian failure 
(POF). In mice FoxL2 is expressed throughout ovarian development, in the postnatal 
ovary it is particularly found in the granulosa cells of primordial follicles and the 
concentration of FoxL2 slowly decreases as the ovarian follicle progresses further 
through folliculogenesis (Uda et al., 2004). In mouse models lacking FoxL2 there 
was normal primordial follicle formation. However, within two weeks PD very few 
ovarian follicles were growing follicles, and there was a lack of secondary follicles 
within the FoxL2 deficient ovaries. This became more defined by week 8 where the 
control ovary showed follicles within a range of different developmental stages 
whereas, in FoxL2 deficient mice almost all of the oocytes where still surrounded by 
a single layer of mostly flattened granulosa cells, though interestingly the oocytes 
appeared to be enlarged. This indicates that granulosa cell proliferation had been 
disrupted so they were unable to complete their transition from being flattened to 
being cuboidal in shape (Schmidt et al., 2004; Uda et al., 2004). FoxL2 therefore, 
appears to be important for somatic pre-granulosa cell differentiation required for the 
transition from primordial follicle to primary follicle.  
 
1.4.4 TGF-β and Smads 
 
A number of members of the TGF- β family have been implicated to play a role 
in primordial follicle activation, including anti-mullerian hormone (AMH), bone 
morphogenetic proteins (BMP) and growth differentiation factor-9 (GDF9) (Adhikari 
and Liu, 2009). AMH is expressed in the granulosa cells of activated follicles but not 
the pre-granulosa cells of the primordial follicles (Baarends et al., 1995) and is 
thought to inhibit the activation of the primordial follicles and reduce the activated 
follicles’ responsiveness to FSH (Durlinger et al., 2001; Durlinger et al., 1999; 
Durlinger et al., 2002). GDF-9 is secreted by the oocytes (Erickson and Shimasaki, 
2000) and its expression correlates with the primordial activation as it is only 
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observed in the primary and secondary follicles but is not in the primordial follicles 
(Dong et al., 1996; Hayashi et al., 1999). BMP-4 and BMP-7 are expressed in the 
theca cells and are part of the BMP system, which is known to be involved in both 
oocyte development and the control of granulosa cell proliferation and differentiation 
(Shimasaki et al., 1999).  
Using a knockout mouse model of AMH it was shown that a deficiency in AMH 
caused an increased number of primordial follicles to be activated, thereby leaving a 
smaller proportion of primordial follicles at both 4 and 13 months. There was a rapid 
depletion of the primordial follicle pool with only 38 on average being found at 13 
months in the AMH deficient mice compared to 225 in the control (Durlinger et al., 
1999). A role of AMH in suppressing follicle activation was also seen in human 
ovarian follicles (Carlsson et al., 2006).  
Similarly, exposure to BMP-4 in rat ovaries in vivo resulted in an increase in 
primordial follicle activation to 60% from 53% in the untreated ovaries. Likewise, in 
BMP-7 exposed rat ovaries there were significantly less primordial follicles with 
only 56.5% of the proportion found in the control rats, leaving a mean of 416 
primordial follicles in BMP-7 exposed ovaries compared to 661.4 primordial 
follicles in the control ovaries. Consequently, a significant fold decrease in 
primordial follicles was seen in the in the BMP-7 exposed rats compared to the 
controls (Lee et al., 2001) and a similar result was also seen in the mouse ovary 
(Shimasaki et al., 1999). Culturing with anti-BMP-4 antibody in vitro caused a 
significant decrease in follicle numbers after 8 days and the follicle number 
continued to decrease the longer the ovaries are exposed (Nilsson and Skinner, 2003).  
Exposure to increased levels of GDF-9, after 10 days resulted in a 29% reduction 
in the number of primordial follicles, a 30% increase in primary follicles and a 60% 
increase in small preantral follicles (Vitt et al., 2000). Addition of GDF-9 in vitro 
also resulted in increased activation of the ovarian follicles in cortical strips of 
human ovarian tissue (Hreinsson et al., 2002). The reverse of this was observed in 
GDF-9 null mice which were infertile. They lacked corpora lutea which appeared to 
be due to follicle development being disrupted at the very early stages of 
folliculogenesis as no secondary follicles were formed (Dong et al., 1996).  
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Smads are a family of signal transduction proteins that transmit TGF-β signals 
from the cell surface to the nucleus. Smad3 is found in the oocytes of primordial and 
primary follicles (Xu et al., 2002). Smad3 deficient females were classified as 
infertile as they were unable to produce pups. At PD2 Smad3 deficient mice had 
significantly fewer primary follicles. By PD18 Smad3 deficient ovaries had 
approximately 61% more primordial follicles and 40% fewer growing ovarian 
follicles compared to the control. This became even more pronounced at PD90 where 
there was a 2.7 fold increase in the number of primordial follicles in the Smad3 
ovaries and 3 fold fewer growing ovarian follicles compared to the control (Tomic et 
al., 2002).  
In summary, members of the TGF- β family including AMH, BMP-4, BMP-7 
and GDF-9, alongside Smad3, which is part of the signalling pathway for AMH and 
GDF-9, have been shown to play a role both in the activation and dormancy of the 
primordial follicles. Low levels of AMH and increased levels of BMP-4, BMP-7 and 
GDF-9 cause increased primordial follicle activation. A decrease in BMP-4 and 
Smad3 resulted in less activation and the loss of the primordial follicles directly from 
the primordial follicle pool. 
 
1.4.5 Steroid Hormones 
 
Steroid hormones have been shown to play a role in primordial follicle activation 
and are also known to be involved in follicle formation (Britt et al., 2004; Kezele and 
Skinner, 2003).  Changing the steroid hormone environment by injecting androgens 
or aromatase inhibitors has been shown within the fetus of both sheep and baboons to 
impact the size of the primordial follicle reserve later on in life (Steckler et al. 2005, 
Albrecht and Pepe, 2010). A number of studies have shown that treatment with 
steroid hormones inhibits the activation of the primordial follicles (Britt et al, 2004, 
Vendola et al. 1999, Kezele and Skinner 2003). 
Aromatase knockout mice have a reduced number of primordial follicles. 
However, treatment of the aromatase knockout mice at 7 weeks old with oestradiol 
for 21 days reversed these consequences so that these mice were seen to have no 
significant difference in the number of primordial follicles in comparison to the 
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control (Britt et al; 2004). Similarly, when both prenatal and newborn mouse ovaries 
were treated with oestradiol or progesterone in vitro, there was a reduction in 
primordial and primary follicles (Kezele and Skinner 2003, Chen et al. 2007). 
The role of androgen was studied in rhesus monkeys. These monkeys were 
exposed to androgens resulting in an increase in the activation of primordial follicles 
to become primary follicles shown by an increase of 50% in primary follicles in 3 
days. The longer the ovaries were exposed the more primary follicles were found in 
the monkey ovaries with a 75% increase in 5 days and 130% increase in 10 days. It is 
thought that androgens increase primordial follicle activation through IGF-I 
signalling as the levels of IGF-I and IGF-I receptor mRNA are seen to increase 
(Vendola et al., 1999).  
It is hypothesised that the role of steroids in primordial follicle activation is 
limited to just after the initial wave of follicle activation (Kezele and Skinner 2003, 
Fortune et al. 2013). Culturing bovine fetal tissue older than 140 days with oestradiol 
did not have any impact on activation. In fetal tissue that was younger than 140 days 
treatment with oestradiol caused an increase in primordial follicle activation (Fortune 




The activation of the primordial follicles is the beginning of the process of 
folliculogenesis (Binelli and Murphy, 2010; McGee and Hsueh, 2000). Once 
activation of a primordial follicle has occurred it will either continue through its 
progressive developmental stages until a mature oocyte is ovulated or it will undergo 
atresia, which can occur at any point (Scaramuzzi et al., 2011; Webb and Campbell, 
2007; Webb et al., 2004). As mention above, folliculogenesis has several key 
developmental stages progressing from the primordial follicle to primary, preantral, 
antral and finally the pre-ovulatory stage (Binelli and Murphy, 2010; McGee and 
Hsueh, 2000) (see figure 1.5). At each stage both the oocyte and granulosa cells of 
the ovarian follicles are co-ordinated to develop together to ensure the correct 
number of mature oocytes are ovulated depending on the species. The process of 
folliculogenesis appears to be similar in most species however, the length of time it 
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takes and both follicle and oocyte size are species dependent (Evans, 2003; Mihm 
and Evans, 2008).  
 
 
Figure 1.5: Folliculogenesis. Folliculogenesis can be separated into a) early 
folliculogenesis and b) late folliculogenesis. Early folliculogenesis is under paracrine 
control and is gonadotrophin independent whereas, late folliculogenesis is under 
endocrine control and is gonadotrophin dependent. 
 
 
1.5.1 Early Folliculogenesis: Primordial to Preantral 
 
Early folliculogenesis is a reference to the first few stages from the primordial 
stage to primary and through to the pre-antral stage of development (Binelli and 
Murphy, 2010; McGee and Hsueh, 2000). The difference between early and late 
folliculogenesis is primarily based upon how it is controlled. Early folliculogenesis is 
mainly under the control of paracrine factors (Kol and Adashi, 1995) and it is well 
established that gonadotrophins are not essential for the development of preantral 
follicles. This is highlighted by a number of studies where the lack of follicle-
stimulating hormone (FSH) or FSH receptor had no impact on early folliculogenesis. 
However, there is evidence that gonadotrophins affect the development of preantral 
follicle in mice (Dufour et al., 1979; Edwards et al., 1977).  
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Folliculogenesis begins with the activation of primordial follicles. When a 
primordial follicle is activated there is an increase in the size of the oocyte and the 
flattened granulosa cells become cuboidal (McGee and Hsueh, 2000; Picton, 2001). 
Oocyte secreted factors GDF-9 and BMP-15 co-operate to regulate the proliferation 
of the cells within the follicle (Edwards et al., 2008). During the early stages of 
folliculogenesis GDF-9 plays the greater role in regulating the ovarian follicle cell 
proliferation (Dong et al., 1996; Vitt et al., 2000) whereas, in the later stage of 
folliculogenesis it is BMP-15 that plays the larger role (Galloway et al., 2000; 
Juengel et al., 2002; Juengel et al., 2004; Yan et al., 2001). The granulosa cells of the 
primary follicles continue to expand through mitotic divisions so the single layer of 
granulosa cells becomes multilayered surrounding the oocyte to form a pre-antral 
follicle.  
During development to the pre-antral follicle stage key structural characteristics 
including the zona pellucida (ZP) and theca cells are formed (Knight and Glister, 
2006; Oktem and Urman, 2010). These different regions of the ovarian follicle all 
play different parts in promoting its continuous development (Oktem and Urman, 
2010). The ZP is formed from exported glycoproteins (Fair et al., 1997; Picton et al., 
1998); it has a number of important roles in reproduction during oogenesis, 
fertilisation and implantation. However, in folliculogenesis its function is to protect 
the oocyte and support the communication between the oocyte and its surrounding 
granulosa cells (Wassarman et al., 1999). Whereas, the formation of the theca cell 
layer provides the ovarian follicle with an independent blood supply (Young and 
McNeilly, 2010), as well as being the source of androgen synthesis (Lee et al., 2004; 
Nilsson and Skinner, 2002).  
The process of folliculogenesis depends upon coordination between all the 
different parts of the ovarian follicles (Canipari et al., 2012). It is generally thought 
that the oocyte promotes the granulosa cells to begin proliferating. However, 
granulosa cells are also required for oocyte growth, differentiation, meiosis and 
transcriptional activity (van den Hurk and Zhao, 2005). In order to have a healthy 
ovarian follicle the growth of the oocyte and various components of the ovarian 
follicle must be balanced, one factor thought to regulate this is kit ligand (KL) 
(Cecconi et al., 2004; Hutt et al., 2006; Otsuka and Shimasaki, 2002; Wu et al., 
 41 
2004). To maintain communication between the granulosa cells and the oocyte, 
physical links known as transzonal projections are formed between them. Transzonal 
projections stretch from the granulosa cell through the ZP to the oocyte (Combelles 
et al., 2004), and play an important role in ovarian folliculogenesis and are essential 
for maintaining the overall health of the follicle (Albertini et al., 2001; Cecconi et al., 
2004; Eppig, 2001). At the oocyte membrane transzonal projections form gap 
junctions that are regions specialized as transmembrane channels. These gap 
junctions allow the exchange of ions, electrical impulses and small molecules 
between the oocyte and granulosa cells (Canipari et al., 2012; Cecconi et al., 2004; 
Fair, 2010; Grazul-Bilska et al., 1997). The transport of key components from the 
granulosa cells to the oocyte is required for the oocyte’s growth and metabolism 
(Moor, 1988; Rodgers et al., 2000). The gap junctions are also thought to regulate 
folliculogenesis and ovarian follicle loss through atresia (Grazul-Bilska et al., 1997). 
Connections via gap junctions are not only found between the oocyte and the 
granulosa cells but also from granulosa cell to granulosa cell enabling the 
bidirectional communication between these different regions of the ovarian follicle to 
maintain the correct growth and thereby, health of the ovarian follicle (Elvin et al., 
2000; Fair, 2010; Nagyova et al., 2000).  
The majority of the oocyte growth is completed during early folliculogenesis 
before the ovarian follicle reaches the antral stage of development. During this time 
the oocyte increases in volume by 100-300 fold and is supported by the increasing 
number of surrounding granulosa cells (Griffin et al., 2006). The cytoplasm in the 
growing oocyte accumulates a range of substrates including glycogen granules, lipid 
droplets, protein and mRNA. There are also structural changes and redistribution of 
the endoplasmic reticulum and Golgi complexes indicating the high synthetic activity 
within the oocyte (Fair et al., 1997; Picton et al., 1998; Sturmey et al., 2009).  
 
1.5.2 Late Folliculogenesis: Antral to Ovulation 
 
Late folliculogenesis refers to the last few stages from antrum formation to 
ovulation (Binelli and Murphy, 2010; McGee and Hsueh, 2000). Antrum formation 
appears to be the crossover between early and late folliculogenesis as it is under 
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paracrine control, but is also influenced by gonadotrophins such as FSH (Cortvrindt 
et al., 1997; Monti and Redi, 2009; Zuccotti et al., 2011). However, the transition 
from pre-antral to antral is still primarily under the control of TFG-β ligands 
produced by the granulosa cell and theca cells rather than the gonadotrophins (Diaz 
et al., 2008). At the antral stage of folliculogenesis the follicles are gonadotrophin-
dependent (Edson et al., 2009; Webb et al., 2007), with the progression through the 
antral stage to ovulation being dependent on the pituitary-secreted gonadotrophins 
FSH and luteinizing hormone (LH). Their importance is highlighted by a lack of LH 
receptors resulting in follicles not progressing beyond the antral stage (Zhang et al., 
2001) and the lack of FSH causing folliculogenesis to stop before the antral 
developmental stage (Burns et al., 2001; Danilovich et al., 2000; Dierich et al., 1998). 
In the luteal-follicular transition there is an intercycle rise of FSH (Mais et al., 1987; 
Messinis et al., 1993), which allows a small cohort of antral follicles to survive 
atresia due to the survival actions of FSH (McGee and Hsueh, 2000). FSH 
accumulates in the follicular fluid in follicle recruitment and stimulates the granulosa 
cells to produce steroids (McNatty et al. 1975). LH stimulates the theca cells to 
produce androgens; which are transferred into the granulosa cells, and under the 
influence of FSH, are aromatized into oestrogens (Hillier et al., 1994). Androgen and 
oestrogen are important for the continued proliferation and differentiation of the 
granulosa cells (Drummond et al., 1999; Findlay and Drummond, 1999; Findlay et 
al., 2000).  
Morphologically the antral stage of development is defined by the formation of 
the antral cavity (Boland et al., 1994). The formation of its antral cavity occurs when 
the follicles reach a size of 200-500m again depending on the species (Picton et al., 
1998) at which point the oocyte is about 80% of the final size (Durinzi et al., 1995; 
Szybek, 1972). Alongside the formation of the antrum there is the production of 
follicular fluid which is formed from components from the bloodstream and 
surrounding granulosa cells (Clarke et al., 2006). The follicular fluid contains many 
molecules including oxygen, carbohydrates, amino acids, growth factors and 
hormones amongst other factors (Sutton et al., 2003). The formation of the antral 
cavity triggers a divergence in morphology and function of the granulosa cells into 
mural granulosa cells and cumulus cells. The mural granulosa cells line the follicle 
 43 
wall whereas, the cumulus cells are found around the oocyte (Zuccotti et al., 2011); 
the formation and proliferation of both are due to FSH activating the cAMP/protein 
kinase A pathway (Richards, 2001a).  
Circulating levels of FSH appears to play the main role in controlling follicle 
growth and support a small group of antral follicles to grow until the granulosa cells 
of the largest follicle begins to produce oestradiol and inhibin. The large follicle is 
now referred to as the dominant follicle and it is dependent on LH, and the oestradiol 
and inhibin it produces suppresses FSH secretion to stop the other subordinate 
follicles from growing (Hennet and Combelles, 2012; Hunter et al., 2004). Although 
oestrogen normally suppresses gonadotrophin production, it later results in a surge of 
LH and FSH, this surge causes the expansion of the cumulus-oocyte complex, the 
loss of the gap junctions, the maturation of the oocyte and for it to be ovulated 
(Binelli and Murphy, 2010).  
In order for the oocyte to become mature both nuclear and cytoplasmic 
maturation must occur so a healthy gamete is formed (Eppig, 1996). Cytoplasmic 
maturation refers to the development of the mechanisms needed for fertilisation, the 
formation of the pronuclei and the first embryonic divisions (Ajduk et al., 2008; 
Ferreira et al., 2009).  Nuclear maturation refers to the resumption of meiosis I to 
metaphase II where it becomes arrested again: the oocyte is now considered to be 
mature. The resumption of meiosis is triggered by a surge in LH that restrains the 
inhibitory factors that normally prevent this from happening, resulting in the 
breakdown of the germinal vesicle, condensation of the chromosomes, spindle 
formation and the formation of the 1st polar body (Ledan et al., 2001; Mehlmann, 
2005; Perry and Verlhac, 2008; Tripathi et al., 2010, Ledan et al 2001, Perry and 
Verlhac 2008, Tripathi et al 2010). 
 
1.5.3 Follicular Atresia 
 
As mentioned above the primordial follicle pool is established early in fetal life 
and is generally accepted as the only source of oocytes. Within the ovary hundreds of 
thousands of primordial follicles exist in a female at birth (Hirshfield, 1991). 
However, the majority of these primordial follicles will undergo atresia (Hsueh et al., 
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1994; Tilly et al., 1991). For example in the human of the 600,000 – 700,000 ovarian 
follicles present at birth only around 400 will complete folliculogenesis to produce a 
mature oocyte (Block, 1953, Baker, 1963, Gougeon and Chainey, 1987, Richardson 
et al., 1987, Forabosco et al., 1991; Faddy et al., 1992; Faddy and Gosden, 1996). 
Follicular atresia is identified through the arrested development of ovarian 
follicles and the beginning of degeneration and can occur at any point within the 
process of folliculogenesis. Degeneration impact all components of the ovarian 
follicles i.e. the granulosa cells, theca cells, basement membrane and the oocyte itself 
(Irving-Rodgers et al., 2009). Cell death pathways are key to the process of atresia 
and have been observed in both oocyte and the granulosa cells (Hussein, 2005; 
Johnson, 2003). Granulosa cell apoptosis is thought to be the main mechanism of 
follicular atresia (Manabe et al., 2004). 
Primordial follicles are activated as a small cohort and this cohort will decrease 
in number as they progress through the various stages of folliculogenesis (Fortune, 
1994; Macklon and Fauser, 1999), due to loss by atresia. This is thought to be one 
reason very few of the primordial follicles formed will ever produce a mature oocyte 
(Fortune, 1994; Morbeck et al., 1992). 
Follicular development and oocyte development are inter-dependent and the 
oocyte’s capability to be fertilised is dependent on how it develops through the 
various stage of folliculogenesis in the ovarian follicle. Oocyte quality during this 
process is known to be one factor that determines whether an ovarian follicle will 
undergo atresia or continue through folliculogenesis to become dominant and be 
ovulated, as advanced atresia in ovarian follicles is associated with its oocyte being 
of poor quality (Blondin and Sirard, 1995; Hendriksen et al., 2004; Salamone et al., 
1999). Therefore the loss of follicles through atresia may be one way to ensure an 
oocyte of good quality is ovulated. 
 
1.6 Folliculogenesis in vitro 
 
Many studies have examined folliculogenesis in vitro and this has led to a 
number of different methods being established to grow ovarian follicles from 
different stages of their development including primordial, pre-antral and antral 
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follicular stages. These include gel droplets (Itoh et al., 2002; Loret de Mola et al., 
2004; Oktem and Oktay, 2007; Wandji et al., 1996a), calcium alginate droplets 
(West et al., 2007; Xu et al., 2006), microporous membranes (Eppig and O'Brien, 
1996; Loret de Mola et al., 2004) and v-bottom culture plates (Gutierrez et al., 2000; 
Thomas et al., 2007; Thomas et al., 2001), allowing the ovarian follicles to be 
cultured as organ cultures, in groups or as individual follicles.  
It was first discovered in the rodent model that it was possible to culture ovarian 
follicles from the primary and secondary stage of development, in vitro to a point 
where the ovarian follicles and their oocytes had developed sufficiently enough that a 
mature oocyte could be collected (Cortvrindt et al., 1996; Eppig and Schroeder, 
1989; Spears et al., 1994). The study used a mouse model to produce viable offspring 
entirely in vitro starting at the primordial follicle stage. The study reported the birth 
of a single live pup (Eppig and O'Brien, 1996). This system was later improved to 
increase the number of offspring produced and consisted of two steps (O'Brien et al., 
2003). The first step was to culture the whole ovary of newborn mice to achieve 
growth from the primordial follicle to secondary follicle stage. The second step was 
the isolation of the oocyte-granulosa cell complexes from the secondary follicles 
through enzymatic dissociation, which were then further cultured to gain competent 
oocytes. The rate of primordial follicle activation in the mouse in vitro is similar to 
that seen in vivo (Eppig and O'Brien, 1996).  
Unfortunately, it has not been possible to directly transfer the techniques used in 
the mouse to larger mammals, such as the bovine or the human, as the ovaries are too 
large to be cultured as whole organs. Culturing the ovary as a whole leads to anoxia, 
depletion of nutrients and accumulation of metabolites in the inner medulla causing 
necrosis. The stroma is also too tough to be able to use enzymatic dissociation since 
there is a risk of damaging the oocytes with this treatment (Telfer et al., 2000; 
Thomas et al., 2003; Wandji et al., 1996b). To avoid whole ovarian culture, which is 
impractical in larger mammals, systems were developed to utilise the ovarian cortex 
to successfully activate primordial follicles (Braw-Tal and Yossefi, 1997; Wandji et 
al., 1996a; Wandji et al., 1997). 
 The shape and density of the stroma influences the rate of activation and growth 
of the primordial follicles, with flattened strips showing a greater level of activation 
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and growth (Telfer et al., 2008), compared to those in solid cubes (Hovatta et al., 
1997). The activation of primordial follicles within cortical strips allows follicles to 
grow as far as the pre-antral stage. However, beyond this stage of development the 
large portion of stroma surrounding the pre-antral follicles inhibits their ability to 
progress further. This therefore, led to a two-step culture system being developed in 
large mammals. The primordial follicles were first activated and grown in the 
cortical strips of the ovarian cortex and the second step was for the secondary 
follicles to be mechanically isolated from the ovarian tissue and further cultured 
individually with very little stroma, to allow the ovarian follicles to continue through 
folliculogenesis, although this has not yet produced a mature oocyte (Hovatta et al., 
1999; McLaughlin and Telfer, 2010; Telfer et al., 2008). It is thought that a third step 
must be developed to aspirate and mature the oocyte-cumulus complexes which will 
allow the full process from primordial follicle to support oocyte maturation in vitro 
for larger mammals (Telfer and Zelinski, 2013). 
 
1.7  Research Aims 
 
The aim of this research is to gain a better understanding of the primordial 
follicle population. This will be achieved by: 
 
 Exploring the role of the PI3K pathway in primordial follicle activation and 
subsequent growth and viability. 
 Examining if activation via the PI3K pathway has any impact on the 
development of the ovarian follicles through folliculogenesis.  
 Exploring the location and distribution of the ovarian follicle populations, 
including the primordial follicles, in the ovary and establishing if their 
location influences ovarian follicle health. 
 Examining if the bovine is a good model of human primordial follicle 
activation and subsequent growth in an in vitro culture system. 
 
I hypothesise that using the bpV (HOpic) and 740 Y-P to up regulate the PI3K 
pathway in the bovine model will cause increased primordial follicle activation. I 
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also hypothesise that the bovine will be a good model of human primordial follicle 
activation in vitro and that there will be a small population of primordial follicles 














Chapter Two:  



















2.1 Collecting Ovarian Samples 
 
The majority of the materials and methods in this section are based upon the 
ovarian culture systems developed and described by McLaughlin and Telfer, 2010 
and Telfer et al., 2008. 
 
2.1.1 Bovine Tissue 
 
Bovine ovaries were collected from the local abattoir. The animals ranged 
between 10-14 months in age and were in different stages of their estrous cycle. The 
ovaries were transported in M199 (HEPES buffered) medium supplemented with 
sodium pyruvate (2mM), L-glutamine (2mM), bovine serum albumin (BSA) 
(3mg/ml), penicillin G (75μg/ml), streptomycin (50μg/ml) and amphotericin B 
(2.5μg/ml) (all chemicals from Sigma Chemicals, Poole, Dorset, UK). Before being 
used the medium was filtered through a sterilized filter system (Corning Costar 
Europe, Badhoevedorp, The Netherlands) and was approximately 30-38°C on arrival 
at the laboratory. 
 
2.1.2 Human Tissue 
 
Human biopsies were obtained after informed consent from women aged 
between 28-40 undergoing an elective Caesarean section at local hospitals (LREC 
10/S1101/24). The tissue was transported in Leibovitz medium (GIBCO BRL, Life 
Technologies Ltd.) supplemented with sodium pyruvate (2mM), L-glutamine (2mM), 
human serum albumin (HSA) (3mg/ml), penicillin G (75µg/ml) and streptomycin 
(50µg/ml) (all chemicals from Sigma Chemical). The samples range from 435mm 
to 647mm in size. Before being used the medium was filtered through a sterilized 






2.2 Tissue Dissection in Preparation for Tissue Culture 
 
2.2.1 Bovine Leibovitz Medium 
 
Leibovitz medium (GIBCO BRL, Life Technologies Ltd.) was supplemented 
with BSA (3mg/ml), sodium pyruvate (2mM), L-glutamine (2mM), penicillin G 
(75µg/ml) and streptomycin (50µg/ml) (all chemicals from Sigma Chemical). Before 
being used this medium was passed through a sterilized filter system (Corning Costar 
Europe) and heated to 37°C. From here on it is referred to as bovine Leibovitz. 
 
2.2.2 Human Leibovitz Medium 
 
Leibovitz medium (GIBCO BRL, Life Technologies Ltd.) was supplemented 
with HSA (3mg/ml), sodium pyruvate (2mM), L-glutamine (2mM), penicillin G 
(75µg/ml) and streptomycin (50µg/ml) (all chemicals from Sigma Chemical). Before 
being used the medium was passed through a sterilized filter system (Corning Costar 
Europe) and heated to 37°C. From here on it is referred to as human Leibovitz. 
 
2.2.3 Dissection of Bovine Ovaries to Obtain Cortical Strips 
 
The ovarian samples the bovine ovaries were transported to the laboratory 
where they were placed into a laminar flow hood and rinsed in 70% ethanol. The 
ovaries were examined for areas where there appeared to be no growing follicles and 
the cortex was removed from the surface of the ovary to a depth of 1-2mm at these 
locations using a surgical blade (see figure 2.1). These cortical strips were then 
placed in bovine Leibovitz and examined under a light microscope, with a heated 
plate set to 37°C to maintain the temperature of the medium. The cortical strips were 
dissected to remove any areas which contained follicles that were 40µm or larger in 
diameter. Those areas without any large follicles were further dissected to a reduced 





2.5 Tissue Culture  
 
2.5.1 Bovine McCoy’s Medium 
 
McCoy’s medium (GIBCO BRL. Life Technologies Ltd.) was supplemented 
with L-glutamine (3mM), penicillin G (0.1mg/ml), streptomycin (0.1mg/ml), 
transferrin (2.5µg/ml), selenium (4ng/ml), BSA (1mg/ml) and bovine insulin 
(10ng/ml) (all chemicals from Sigma Chemical). This medium was passed through a 
sterilized filter system (Corning Costar Europe) before being used. The medium was 
equilibrated in a humidified incubator at 37°C with 5% CO2 and further 
supplemented with ascorbic acid (50µg/ml) and recombinant human (rh)FSH 
(1ng/ml) (Sigma Chemical) just before being used. From here on this medium is 
referred to as bovine McCoy’s. 
 
2.5.2 Human McCoy’s Medium 
 
McCoy’s medium (GIBCO BRL. Life Technologies Ltd.) was supplemented 
with L-glutamine (3mM), penicillin G (0.1mg/ml), streptomycin (0.1mg/ml), 
transferrin (2.5µg/ml), selenium (4ng/ml), HSA (1mg/ml) and human insulin 
(10ng/ml) (all chemicals from Sigma Chemical). This medium was passed through a 
sterilized filter system (Corning Costar Europe) before being used. The medium was 
further supplemented with ascorbic acid (50µg/ml) and rhFSH (1ng/ml) (Sigma 
Chemical) and equilibrated in a humidified incubator at 37°C with 5% CO2 just 
before being used. The medium from here on is referred to as human McCoy’s. 
 
2.5.3 Culturing Bovine and Human Cortical Strips 
 
The dissected cortical strips or the tissue that had been treated with 740 Y-P 
or bpV (HOpic) (see section 2.6) were cultured individually in 300μl of bovine or 
human McCoy’s based on the respective species of the tissue in 24 well plates 
(Corning Costar Europe) (see figure 2.2). The plates were placed into a humidified 
incubator at 37°C with 5% CO2 for 6 days. Every 48 hours 150µl of the medium in 
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2.7 Histological Processing 
 
2.7.1 Tissue Fixation and Processing 
 
After completing the cultures the tissue was fixed in 4% paraformaldehyde 
(ADAMS, Leeds, UK) for approximately 48 hours at room temperature. The 4% 
paraformaldehyde was then removed and replaced with increasing concentrations of 
ethanol; 70%, 90%, 100% for approximately 1 hour for each concentration. The 
tissue samples were then removed from the 100% ethanol and transferred to plastic 
moulds (Polyscience Inc., Warrington, U.S.A) filled with cedar wood oil (Fisher 
Scientific, Loughborough, Leicestershire, UK) for approximately 24 hours. The 
cedar wood oil was then removed and replaced with toluene (Fisher Scientific) for 30 
minutes in a fume hood. The tissue was then placed in paraffin wax (McCormack 
Scientific, St Louis, Mo) in a 60°C oven; the paraffin wax was then changed three 
times into fresh paraffin wax at hour intervals. On the last wax change the tissue was 
embedded into the wax ensuring a thin layer of wax was between the bottom of the 
plastic mould and tissue. This was then placed to cool at -4°C.  
 
2.7.2 Tissue Sectioning and Mounting 
 
The tissue was sectioned on a microtome (Leica UK Ltd, Milton Keynes, 
UK) at a thickness of 6µm. Bovine tissue was placed onto polylysine slides (Thermo 
Scientific, Loughborough, UK ) and human tissue was placed on Superfrost Plus 
slides (Thermo Scientific). The tissue was placed onto their respective slide type by 
floating the sections in a water bath at 42°C. The tissue was dried overnight in a 
37°C oven. 
 
2.7.3 H&E Staining 
 
Sections were de-waxed in xylene for 30 mins and then placed through 
decreasing concentrations of ethanol at 100%, 90% and 70% then into water to 
rehydrate the sections. The sections were then placed into Haematoxylin (BDH 
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Laboratory Supplies Poole, UK) for 3.5 minutes, then rinsed under running water 
then briefly dipped in acid alcohol and again rinsed in running water. Sections were 
placed into Scotts tap water substitute for 3 minutes and rinsed in running water for 3 
minutes. Sections were then placed in an eosin solution (1:1) (Sigma Chemicals) for 
2 minutes then dipped into running water before being transferred into potassium 
aluminium solution for 3 minutes. The sections were again rinsed in water before 
passing through increasing concentrations of ethanol at 70%, 90% and 100% to 
dehydrate the sections. The sections were then placed in xylene for 15 minutes 
before being mounted using DPX (BDH Laboratory Supplies) and glass cover slips 
(BDH Laboratory Supplies). 
 
2.8 Analysis of Follicle Development and Health in Cortical Strips  
 
In the bovine every tenth section of the mounted cortical strips were counted 
to prevent double counting of the ovarian follicles, as an ovarian follicle with the 
germinal vesicle present would span more than one section. Only follicles that had a 
germinal vesicle and nucleolus were included in the analysis. In the human tissue all 
sections were analyzed. Each follicle was counted and assessed in the section where 
it had the largest diameter with the germinal vesicle and nucleolus present. The 
follicles were classified as quiescent, primary or secondary based on their 
morphology (vanWezel and Rodgers, 1996; Wandji et al., 1996b) (see figure 2.3). (1) 
Quiescent follicles included both primordial follicles and transitory follicles. 
Primordial follicles consisted of an oocyte surrounded by a single layer of flattened 
granulosa cells and transitory follicles had a mixture of flattened and cuboidal 
granulosa cells surrounding the oocyte. (2) Primary follicles consisted of a single 
layer of cuboidal granulosa cells surrounding the oocyte. (3) Secondary follicles had 
two of more layers of granulosa cells surrounding the oocyte.  
Follicle health was based on: (1) general circularity of the oocyte, (2) 
integrity of the oolemma in the oocyte, (3) presence of a germinal vesicle and 
nucleolus in the oocyte and (4) that 85% of the granulosa cells were healthy. Each 
follicle was classified as healthy if it met these criteria and unhealthy if the follicle 
did not fit these criteria.  
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Each ovarian follicle was measured across its whole diameter at its largest 
and then at a 90° angle to the first measurement a second measurement was taken 
(see figure 2.3). The oocyte diameter were measured twice along the same lines as 
those used to measure the follicle diameter. The average follicle diameter and oocyte 
diameter was established from these two measurements.  
The concentration of ovarian follicles was estimated within the cortical strips 
of both the human and bovine. In the bovine 6 photos were periodically taken 
through each of the cortical strips. Using Image J 1.44g (Rasband W.S, National 
Institutes of Health, USA, http://imagej.nih.gov/ij/) it was possible to calculate the 
volume of each of the photographed sections. The number of ovarian follicles in the 
photograph sections were counted and used alongside the calculated volume to 
estimate the concentration of ovarian follicles in each sample. In human tissue a 
photo was taken at every 20th consecutive section. Again using Image J 1.44g 
(Rasband W.S, National Institutes of Health, USA, http://imagej.nih.gov/ij/) it was 
possible to calculate the volume of each of the photographed sections. The volume of 
the photographed sections amounted to 5% of each cortical strip this was used to 
estimate the total volume of each cortical strip. The total number of ovarian follicles 
was counted in each cortical strip was then used with the estimated total volume to 









Figure 2.3 Follicle Analysis. a) Classification of ovarian follicles is based on 
their morphology as quiescent, primary and secondary follicles. The health of the 
ovarian follicles was also based on morphology and b) represents an example of a 
healthy follicle and c) represents a follicle that would be classified as unhealthy. 
Measurements of follicle diameter and oocyte diameter were taken from each follicle 
d) 2 measurements of the follicle diameter were taken; the first at the largest 
diameter of the follicle and the second at 90° to the first. The oocyte was measured 
twice along the same two lines. 
 
2.9 Statistical Analysis 
 
Ovarian fragments and ovarian follicles were analysed to gain better 
understanding of up regulation of the PI3K pathway, using bpV (HOpic) or 740 Y-P, 
on primordial follicle activation and subsequent development. This thesis also 
explored the distribution of the non-growing and growing follicle populations and 
their viability within the different regions of the ovary. It also compared the 
activation and development of the ovarian follicles of the bovine and human in an in 
vitro culture environment. The ovarian follicle populations were commonly assessed 
in this thesis by comparing the concentration of ovarian follicles in the tissue, the 
distribution of the different developmental stages of the ovarian follicles, the health 
a) 
b) c) d) 
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of the ovarian follicles as well as assessing the size of the ovarian follicles within 
each developmental stage. 
Analysis of the concentration of ovairan follicles and concetration of healthy 
quiescent follicles in each region of the ovary 
Analysis of the concentration of ovarian follicles and concentration of healthy 
quiescent follicles in each regions of the ovary by using Kolmogorov Smirnoff test to 
test for normal distribution of the data. The data were seen to be normally distributed 
therefore, one-way ANOVA was used to statistically compare the data, where this 
test reported a significant difference the groups were compared using the post hoc 
Tukey test. The distribution and health of the ovarian follicles were compared using 














Exploring the Ovarian Medulla as a 





























The experiments in this thesis were performed with the aim of gaining a 
better understanding of the quiescent follicle population therefore, knowing their 
location in the ovary is important. The morphology of the ovary varies widely 
between mammalian species, however in most species it is possible to identify three 
main components; the surface epithelium, the cortex and the medulla (Escobar et al., 
2011) (see figure 3.1). One fundamental morphological difference in the structure of 
the ovary between species is the proportion of the cortex and medulla. Some species 
have very little medulla in their ovaries, such as the mouse, whereas in other species, 
such as the human, there is a large medullary region in the centre of the ovary 
(Jimenez, 2010). Structurally the cortex and the medulla are morphologically distinct 
from one another. The cortex consists of tightly compact connective tissue and is 
poorly vascularised. In contrast, the medulla comprises loosely connected connective 
tissue and is highly vascularised (Escobar et al., 2011).  
In both the bovine and human the distribution of ovarian follicles within the 
ovary is known to be different in each region of the ovary, with around 90% of all 
ovarian follicles located in the cortex. The highest concentration of ovarian follicles 
is found in the outer cortex, with the ovarian follicle concentration progressively 
declining through consecutive inner layers of the ovary. The location of ovarian 
follicles in the ovary is thought to depend upon what stage of follicular development 
they are in (see figure 3.1). The quiescent follicle population is located 
predominately in the outer cortex whereas; the growing follicle population is 
primarily located in the inner cortex and at the cortex-medulla border. Within the 
medulla there are very few ovarian follicles and those present are generally 
considered to be at the later stages of folliculogenesis (Jimenez, 2010; vanWezel and 





Figure 3.1 Structure of the Ovary and Presence of the Ovarian Follicles 
within the Different Regions. From the outer edge of the ovary there is the a) 
surface epithelium, b) outer cortex, c) inner cortex, d) cortex-medulla border and 
finally the e) medulla. Both the b) outer and c) inner cortex contain tightly connected 
connective tissue and are poorly vascularised. The (e) medulla has loosely connected 
connective tissue and is (h) highly vascularised. The (d) cortex-medulla border has 
characteristics of both the cortex and medulla. (f) Non-growing follicles are found 
predominately at the (b) outer cortex whereas, the (g) growing follicles are primarily 
found at the (c) inner cortex and at the (d) cortex-medulla border. 
 
The primordial follicle population is the largest population of ovarian 
follicles within the ovary at any time (Gosden and Telfer, 1987, vanWezel and 
Rodgers, 1996). They are also the ovarian follicle population least impacted by 
cryodamage (Cortvrindt et al., 1997; Hovatta, 2005; Oktay et al., 1997; von Wolff et 
al., 2009), making them the main target for current and developing fertility 
preservation techniques. Understanding that the primordial follicle population is 
primarily in the outer cortex has led to only the cortex to a depth of 1-2mm being 
preserved from ovarian biopsies as part of current clinical practice for fertility 
preservation (von Wolff et al., 2009). Additionally, only the cortex is utilised in in 
vitro research examining primordial follicles (Braw-Tal and Yossefi, 1997; 
McLaughlin and Telfer, 2010; Telfer et al., 2008; Wandji et al., 1996a; Wandji et al., 
1997) in species where culturing the whole ovary is not possible due to its large size 
(Telfer et al., 2000; Thomas et al., 2003; Wandji et al., 1996b). However, a recent 
study by Kristensen et al., 2011 indicated that there is a population of primordial 
follicles in the medulla region in the human ovary. Therefore, by only using the 
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cortex are we losing a potential source of primordial follicles when we discard the 
medulla? 
This chapter will use both bovine and human ovaries that are similar in 
structure with the same dimensions for the proportion of the cortex and medulla 
(Jimenez 2010) to examine the ovarian follicle populations within each region of the 
ovary. The Kristensen et al. 2011 study used neutral red staining to identify ovarian 
follicles within the medulla. Neutral red is a vital stain and therefore, only binds to 
viable ovarian follicles. One aim of this chapter was to therefore explore if the health 
of ovarian follicles was influenced by their location in the ovary, by identifying both 
the healthy and unhealthy follicles. The Kristensen et al. 2011 study also classified 
the developmental stage of each ovarian follicles upon follicle size, with follicles 
<60m being classified the primordial/early primary. In this study the assessment of 
the developmental stage of folliculogenesis will be based on morphology, as this will 
enable a distinction to be made between primordial and early primary (growing) 
follicles. This should provide a better understanding of the location of the quiescent 


















3.2 Materials and Method 
 
3.2.1 Tissue Collection and Dissection 
 
3.2.1.1 Bovine Samples 
 
Bovine ovaries were collected from the local abattoir and transferred to the 
laboratory in M199 medium. Each ovary was disinfected with 70% ethanol in a 
laminar flow hood. Using a surgical blade the superficial 1-2mm of cortex was 
removed from the surface of 8 different bovine ovaries (see figure 3.2 a). A sample 
of the ovarian region under this part of the cortex was then removed to a depth of 
approximately 5-8mm using a surgical blade. The tissue samples (n=8) were then 
fixed in paraformaldehyde for 48hr, processed, mounted and H&E stained as 




Figure 3.2 Outline of Method. a) Bovine ovaries were collected from the local 
abattoir. The outer cortex at the surface of the ovary was removed to a depth of 1-
2mm from the surface of the ovary. At the section where the outer cortex had been 
removed another section of tissue was extracted to a depth of approximately 5-8mm. 
b) Human biopsies were collected from women undergoing elective Caesarean 
sections. The cortex and medulla were separated based on their morphology. All 




3.2.1.2 Human Samples 
 
Human biopsies were collected from 8 different women, aged between 28-38, 
after informed consent from the local hospitals and transported to the laboratory in 
human Leibovitz medium. Each biopsy was placed into fresh human Leibovitz 
medium on arrival for dissection under a laminar flow hood. The more compact 
cortex (usually 1-2mm in depth) was separated from the vascular medulla (usually 2-
5mm in depth) using a surgical blade (see figure 3.2 b). The biopsy samples (n=8) 
were then fixed in paraformaldehyde for 48 hours, processed, mounted and H&E 
stained for analysis; for full description see chapter 2. 
 
3.2.2 Analysis  
 
Follicles in H&E stained samples of the human and bovine ovaries were 
analysed based on their morphology. Ovarian follicles were classified either as 
quiescent follicles, which included both primordial and transitory follicles or as 
growing follicles that included both the primary and secondary follicles. Ovarian 
follicles were also noted to be either healthy or unhealthy based on their morphology 
using criteria described in chapter 2.  
 The location of each follicle was determined, and classified as being in the 
cortex, at the cortex-medulla border or in the medulla based on the morphology of 
the ovarian tissue surrounding the follicle (see figure 3.3). The cortex was classified 
as consisting of tightly compacted stromal cells and was non-vascular. The medulla 
was classified as consisting of less densely compact connective tissue containing 
blood and lymphatic vessels and nerves, used to support the other regions of the 
ovary, thereby defined as being highly vascularised tissue. Often there appeared to be 
no distinction between the medulla and cortex as there were regions in the tissue that 
had characteristics of both cortex and medulla; these were classified as the cortex-
medulla border. Within the bovine tissue the cortex was split into the outer cortex 
and the inner cortex. The outer cortex consisted of the 1-2mm of the ovarian tissue 
taken initially from the surface of the ovary whereas, the inner cortex consisted of 
any cortex found in the 5-8mm sample taken after the initial 1-2mm of the surface of 
the ovary had been removed. Using Image J 1.44g (Rasband W.S, National Institutes 
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of Health, USA, http://imagej.nih.gov/ij/) the concentration of ovarian follicles in 




























3.2.3 Statistical Analysis 
 
 Analysis of the concentration of ovarian follicles and concentration of 
healthy quiescent follicles in each regions of the ovary by using Kolmogorov 
Smirnoff test to test for normal distribution of the data. The data was normally 
distributed therefore; a one-way ANOVA was used to statistically compare the data, 
where this test reported a significant difference the groups were compared 
individually using a post hoc tukey test. The distribution of the ovarian follicles and 
health of the ovarian follicles were compared using chi-squared test. Only p-values 
that were < 0.05 were considered to be significant.  
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3.3 Results.  
 
3.3.1 Concentration of Ovarian Follicle in Each Region of the Ovary 
 
 A significant decrease in the concentration of ovarian follicles was observed 
between the cortex in the human and outer cortex in the bovine to each progressive 
inner layer of the ovary. In the human ovarian samples a mean of 17.42.3 ovarian 
follicles/mm3 were found in the cortex and 5.61.5 ovarian follicles/mm3 in the 
cortex-medulla. No ovarian follicles were found in the medulla (p<0.01) (see figure 
3.4 A). In the bovine there were 169.012.6 ovarian follicles/mm3 in the outer cortex, 
76.9 7.1 ovarian follicles/mm3 in the inner cortex, 32.35.0 ovarian follicles/mm3 in 
the cortex-medulla and 3.90.7 ovarian follicles/mm3 in the medulla (p<0.001) (see 







3.3.2 Distribution of Ovarian Follicles  
 
The distribution of the quiescent and growing follicles was calculated in both 
bovine and human to explore if there were any difference in the distribution 
queiscent follicles and growing follicles in the different regions of the ovary. Table 
3.1 displays a summary of the data collected. 
Ovarian follicles were only observed in the cortex and cortex-medulla border 
in human samples so the distribution of the growing follicles could only be examined 
in these regions. In the cortex 68.62.9% of the ovarian follicles population was 
quiescent and 31.4±2.9% was growing (see figure 3.5 A). This was significantly 
different from the cortex medulla where 26.02.9% of the ovarian follicle population 
was quiescent and 74.0±2.9% were growing (p<0.001). 
In the bovine ovarian tissue samples ovarian follicles were found in all of the 
regions of the ovary. There was a significant difference in the distribution quiescent 
and growing follicles in each of the region of the ovary with statistically less 
quiescent and more growing follicles in the progressively deeper regions of the ovary 
(see figure 3.5 B). The outer cortex contained 61.92.5% quiescent follicles and 
38.12.5% growing. The inner cortex contained significantly less quiescent follicles 
and significantly more growing follicles that the cortex with 43.31.6% were 
quiescent with 56.71.6% growing (p<0.001). The cortex-medullary border 
contained significantly less quiescent follicles and significantly more growing 
follicles that the inner cortex at 23.62.3% quiescent follicles and 76.42.3% 
growing (p<0.001). The medulla contained a low proportion of quiescent ovarian 
follicles at 8.72.4% and a high proportion of growing follicles at 91.32.4% than 
the cortex-medullary border (p<0.01). 
Between the bovine and human there appears to be a similar increase in the 
proportion of ovarian follicles that were growing from the cortex to the cortex-
medulla border. A 31.53.5% and 32.63.5% increase in the proportion of the 
ovarian follicles that were growing follicles in the cortex-medulla border compared 
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3.3.4 Health of the Ovarian Follicles  
 
The health of the quiescent and growing follicles was calculated in both 
bovine and human for each region of the ovary to examine to if the location had any 
impact on the health of the follicles. Table 3.2 displays a summary of the data 
collected. 
The health of ovarian follicles was influence by their location in the ovary in 
both bovine and human samples. The proportion of healthy quiescent follicles was 
seen to decrease significantly from 65.32.5% in the cortex to only 47.16.0% in the 
cortex-medulla border in the human (p<0.05) (see figure 3.6). There was also a 
significant decrease in the health of the growing follicles in the cortex at 58.34.8% 
to only 39.92.5% in the cortex-medulla border (p<0.05).  
In the bovine ovary there was no significant difference in the health of the 
quiescent follicles in the outer cortex at 71.33.3% and the inner cortex at 
70.5.3.1% (p>0.05) (see figure 3.7 and 3.8). However, there was a significant 
decrease in the health of follicles in the cortex-medulla at only 28.84.6% compared 
to the cortex (p<0.001). In the medulla only 16.714.4% of the quiescent follicle 
population were seen to be healthy but too few quiescent follicles were found in the 
medulla region to carry out any statistical tests. The growing follicles displayed no 
significant difference in health with 66.33.6% and 63.52.6% of the ovarian 
follicles being healthy in the outer cortex and inner cortex respectively (p>0.05). 
There was a significant decrease in the health of the growing follicles in the cortex-
medulla border at 27.61.3% compared to the cortex (p<0.001). The growing 
follicles were significant lower in health at only 8.02.6% compared to the cortex-
medulla border (p<0.05).  
In order to compare the difference in the health of the ovarian follicles in the 
different regions of the ovary between the human and the bovine, the outer and inner 
cortex of the bovine were combined (as there was no significant difference in 
follicular health) to create a single cortex group to compare to the cortex-medulla. 
The medulla could not be compared between the two as no ovarian follicles were 
observed in the medulla of the human. The decrease in health of the ovarian follicles 
from the cortex to the cortex-medulla border was seen to be similar at 18.14.1% and 
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18.23.9% for quiescent and growing follicle populations respectively in the human 
(p>0.05) (see figure 3.9). Similarly, the difference in health of the both the quiescent 
and growing follicles did not differ between the cortex and cortex-medulla in the 
bovine at 42.22.7% and 37.92.6% respectively (p>0.05). No comparison could be 
made between the health of the quiescent and growing follicles population in the 
cortex-medulla to the medulla in the bovine as there were too few quiescent follicles 
were found in the medulla region to carry out any statistical tests. However, the 
difference in the health of the ovarian follicles between the cortex and cortex-
medulla was significantly higher in the bovine in comparison to human for both the 
quiescent and growing follicle populations (p<0.05). 
 
Table 3.2: Data Collected from Human and Bovine Samples used to Calculate 
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Figure 3.7 Follicular Health of the Quiescent and Growing Follicles in 
the each Region of the Ovary in the Bovine. Graph displays no change in the 
health of quiescent follicles in the outer and inner cortex but a decrease in the health 
is observed in the cortex-medulla. There is a decrease in the health of the quiescent 
and growing follicles from the outer and inner cortex in comparison to the cortex-
medulla and a further decrease in the health of growing follicle population found in 
the medulla. Means that have different letters are significantly different from one 
another within quiescent and growing follicle populations (p<0.05).  Mean±sem,  
n=8. 
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Figure 3.8 Quiescent and Growing Follicle Health in the Different 
Regions of the Bovine Ovary. Example of the health of quiescent follicles found 
in A) cortex and B) the cortex-medulla border. There is also an example of a healthy 






3.3.5 Concentration of Healthy Quiescent Follicles in Each Region of 
the Ovary 
 
In both human and bovine there was a significant difference in the number of 
healthy quiescent follicles between the different regions of the ovary. In the human 
there were significantly more healthy quiescent follicles in the cortex at 9.92.5 
compared to 1.51.1 healthy quiescent follicles/mm3 in the cortex-medulla and no 
healthy quiescent follicle in the medulla (p<0.001) (see figure 3.10). In the bovine 
there were 78.85.7 healthy quiescent follicles/mm3 in the outer cortex, 27.83.5 
healthy quiescent follicles/mm3 in the inner cortex, 2.80.5 /mm3 in the cortex-
medulla and 0.10.1 healthy quiescent follicles/mm3 in the medulla (p<0.001). 
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3.4 Discussion  
 
The aim of these experiments was to examine the medulla as a potential 
source of ovarian follicles and in particular to explore the location of the quiescent 
follicle population in the ovary. This was done in both bovine and human, which 
have ovaries that are similar in structure with the same dimensions for the proportion 
of the cortex and medulla (Jimenez 2010). The number of ovarian follicles/mm3 was 
seen to decrease in both bovine and human from outer cortex and cortex respectively 
and through the progressive inner layers of the ovary. This agrees with the change in 
concentration of the ovarian follicles from the outer region to the inner regions of the 
ovary previously observed in the bovine and human (Jimenez, 2010; vanWezel and 
Rodgers, 1996). In this study the growing follicles population consisted of 
predominately primary follicles as well as secondary follicles. 
In human no ovarian follicles were observed in the portion of the medulla 
obtained from each biopsy. This differs from the previous study by Kristensen et al., 
2010, where they found ovarian follicles in the medulla at all ages. However, they 
classify ovarian tissue as either cortex or medulla based on distance from the outer 
edge of the ovary. Based on the cortex usually spanning 1-2mm (Kristensen et al., 
2011; von Wolff et al., 2009) the first 1-2mm was classified as cortex and the rest as 
medulla. Within this study the morphology of the tissue based on H&E staining was 
used to identify not only the cortex and medulla but also the cortex-medulla border 
on the basis of structure rather than distance from the edge of the ovary (Escobar et 
al., 2011; vanWezel and Rodgers, 1996). It is likely that the cortex-medulla region 
found in this study was included in the medulla region in Kristensen et al., 2011, and 
that these different methods of classifying the regions of the ovary account for the 
differences. Another factor could be the size of the human biopsies received in this 
study compared to the Kristensen et al., 2011 study, as only a small biopsy of the 
ovary was taking from the caesarean-section patients within this study whereas, in 
the Kristensen et al., 2011 they had much large tissue samples as they received the 
medulla from a whole ovary. Another factor to considered is the range of ages used 
within this study both the human and the bovine ovarian samples range from 28-38 
years and 10-14 months in age respectively and therefore, only taken at a post-
pubertal age whereas, the study Kristensen et al., 2011 were collected from a much 
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wider age range from 3 to 35 years. In the Kristensen et al. 2011 study it was shown 
that the presence of ovarian follicles within the medulla was much more prevalent in 
the pre-pubertal ages which was not explored within this study.  
The decrease in number of ovarian follicles from the outer edge of the ovary 
to the inner regions of the ovary could be due to a number of reasons. It was found 
that the proportion of quiescent ovarian follicles decreased from the cortex in the 
human ovaries and the outer cortex in the bovine ovaries through the progressive 
deeper layers of the ovary. Subsequently, the majority of ovarian follicles in the 
cortex-medulla and medulla were growing follicles, again agreeing with that 
observed in previous studies (vanWezel and Rodgers, 1996). The structure of the 
ovarian follicles and the timing of their formation are thought to influence the 
activation of the ovarian follicles. It is hypothesized that ovarian follicles follow the 
production line hypothesis proposed by Henderson and Edwards in 1968 which 
states that those primordial follicles that are the first to enter meiosis are the first to 
undergo folliculogenesis (Henderson and Edwards, 1968). The primordial follicles in 
the cortex are the last to be made resulting in it having the largest portion of 
quiescent follicles (Hirshfield, 1992; Mork et al. 2012).  
A study on the mouse ovary found that the first primordial follicles are 
formed within the medulla region (Mork et al. 2012). Cells known as progenitors are 
found within the cortex are the cells that give rise to the cortical granulosa cells as 
they proliferate. This timing of formation of the ovarian follicles means that the 
ovarian granulosa cells within these ovarian follicles that are formed earlier and are 
created from the progenitor at an earlier stage in its development (Mork et al., 2012). 
The ovarian follicles with granulosa cells formed in the progenitor’s early 
development may be unable to maintain the dormancy of the quiescent follicles as 
they are proposed to be missing a factor that is acquired at a later stage of the 
progenitor’s development. The follicles that have these granulosa cells are 
predominately found in the medulla region of the ovary (Mork et al., 2012), as a 
result the primordial follicles in the medulla are part of the first wave of primordial 
follicles activated (Hirshfield 1992, Eppig and Handel 2012). Although this has only 
been recorded in the mouse model it is possible that it occurs in other species; the 
change in the distribution quiescent and growing follicles in both the bovine and 
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human showing a lower proportion of quiescent in the inner regions of the ovary 
could indicate that this also occurs these two species. Once an ovarian follicle has 
undergone activation it will either continue though the various stages of 
folliculogenesis until it reaches ovulation or it will undergo atresia (Scaramuzzi et al., 
2011; Webb and Campbell, 2007; Webb et al., 2004). This could account for the 
decrease in the number of ovarian follicles and decrease in the percentage of the 
ovarian follicles that are quiescent in the inner regions of the ovary in comparison to 
the outer regions of the ovary. 
Growing follicles are thought to move away from the outer cortex towards 
the medulla. The change in the physical environment is thought to influence the 
growth process of the ovarian follicles. It has been hypothesised that the more rigid 
ovarian cortex is relatively non-permissive for the growth of ovarian follicles 
whereas the perimedullar zone is thought to be relatively permissive for follicle 
growth. Within this hypothesis it is thought that the biomechanical environment in 
the different zones of the ovary are able to modulate the follicles response to 
hormones. The ovarian follicles are thought to be able to sense a dynamic 
environment in the different zones as they grow to expand outwards and move 
through the stroma into the more permissive environment for growth (Woodruff and 
Shea, 2011). In this study there was a difference in the density of stromal cells in the 
different regions of the ovary, which became progressively less dense from the 
cortex to the inner regions of the ovary. The movement of the growing ovarian 
follicles from the dense stromal region of the outer ovary to the less dense regions of 
the inner region of the ovary might be more permissive for follicular growth, and 
could be another factor contributing to the change in distribution of quiescent and 
primary follicles in each region of both the bovine and human ovaries observed in 
this study.  
There is also a decrease in the health of both quiescent and growing follicle 
populations from the cortex and cortex-medulla, and a further decrease in the health 
of growing follicles found in the medulla of the bovine. The health in both the 
growing and quiescent follicle population showed a similar decrease in the cortex-
medulla compared to the cortex in both species. This indicates that factors impacting 
the health of the ovarian follicles impact both the quiescent and growing follicles 
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populations equally. However, no significant difference was observed in the health of 
the ovarian follicles in the outer and inner cortex of the bovine tissue, indicating that 
the different environments present within the different regions of the ovary could 
influence the health of the ovarian follicles. How ovarian environment might 
influence the process of folliculogenesis is unclear. One factor could be the 
disruption of the interaction of the granulosa cells with the surrounding stromal cells 
of the cortex to induce differentiation of the theca cells, which does not occur with 
medullary stromal cells (Orisaka et al., 2006). The decrease in health could be a 
correlation with the reduction of cortical stromal cells within the cortex-medulla and 
their absence in the medulla itself accounting for a progressive increase in degenerate 
follicles from the cortex to the cortex-medulla border and finally the medulla. The 
higher proportion of degenerate ovarian follicles in the inner regions of the ovary 
could also be attributed to the decrease in the number of ovarian follicles from the 
cortex to the cortex-medulla and medulla as the quality of the ovarian follicles is 
known to be a key factor that causes an ovarian follicle to undergo atresia (Blondin 
and Sirard, 1995; Hendriksen et al., 2004; Salamone et al., 1999). 
Although there is a decrease in the proportion of healthy ovarian follicles in 
the medulla and cortex-medulla, a recent study by Wilken-Jensen et al 2013 has 
indicated that it is still possible for a mature oocyte to be extracted from biopsy 
material left after the cortex has been removed, using human ovarian tissue. 
Currently, in many cases the aim of cryopreserving ovarian tissue is for it to be used 
later to help the individual have a baby. Therefore, from a clinical aspect being able 
to utilise these ovarian follicles from all the regions of the ovary is important 
(Wilken-Jensen et al., 2013). 
In summary, there is a decrease in the number of ovarian follicles from outer 
cortex to the inner regions of the ovary, in both human and bovine ovaries. The 
location of the ovarian follicle population impacts both the distribution of quiescent 
and growing follicles and the health of the ovarian follicles. The ovarian follicles in 
the outer cortex observed to be predominantly quiescent, the proportion of quiescent 
follicles is seen to decline through the progressive inner regions of the ovary. The 
health of ovarian follicles was also reduced from the cortex to the inner regions of 
the ovary in both the quiescent and growing follicle population, indicating the 
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environment of the inner regions of the ovary influences the health of the follicles. 
As a result there are very few healthy quiescent follicles in the inner regions of the 
ovary compared to the cortex, and indeed none were found in the medulla in the 
human biopsies studied. Therefore, when exploring the quiescent follicle population 














Exploring the Bovine as a Model for 




















Studies exploring the role of the PI3K pathway on primordial follicle fate 
have been predominately based in the rodent model. These models have given a good 
indication of the importance of the PI3K pathway in both primordial follicle 
activation (Castrillon et al., 2003; John et al., 2008; Liu et al., 2007; Rajareddy et al., 
2007; Reddy et al., 2008) and dormancy (Liu et al., 2007; Reddy et al., 2009). 
However, it is important to explore if the PI3K pathway plays the same role in other 
species. Rodents are small poly-ovulatory mammals (Milligan et al., 1980) therefore, 
this thesis aimed to explore if the PI3K pathway plays the same role in a large mono-
ovulatory species. The chosen animal model is a large mono-ovulatory species with 
similar attributes in its reproduction and folliculogenesis to the human (Gougeon, 
1986), as this will not only allow the experiments in this thesis to show the role of 
the PI3K pathway in another species, but also give a valuable indication to its role in 
the human.  
Domestic species have been highlighted to be good models for human as the 
ovarian follicle size at each developmental stage and the rate at which the ovarian 
follicles grow is similar (Baerwald, 2009; Gougeon, 1996). In particular, the bovine 
has been indicated to be a good model because they share many characteristics to 
humans in both their reproduction and folliculogenesis. Both the bovine and the 
human are mono-ovulate and undergo estrous/menstrual cycles throughout the entire 
year (Adams and Pierson, 1995; Baerwald, 2009), in contrast to other domestic 
animals which are seasonal breeders, such as sheep (Rosa and Bryant, 2003), or 
polyovulatory, such as the pig (Cortvrindt and Smitz, 2001a; Dziuk, 1977). Bovine 
ovaries are also close in size to the human, with both being approximately 3cm by 
2cm by 1.5cm in size (Adams and Pierson, 1995). The structures observed in bovine 
and human ovaries are also similar and have proportional amounts of cortex and 
medulla (Jimenez, 2010). 
The pool of primordial follicles is established before birth in both species. In 
the bovine there are approximately 133,000 primordial follicles at birth. This number 
remains stable until about the 4th-6th year of life after which the number of primordial 
follicles declines to approximately 25,000 at 10-14 years of age and by 15-20 years 
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of age there are only around 3,000 primordial follicles remaining. The bovine 
reaches reproductive cessation at around 25 years (Erickson, 1966; Erickson, 1976; 
von Saal et al., 1994; Cohen, 2004). At birth in the human there are approximately 
600,000-700,000 primordial follicles. Studies have suggested the number primordial 
follicle declines steadily until around 37 years of age where there are approximately 
25,000 follicles remaining. After 37 years there is thought to be an increased rate of 
decline in the number of primordial follicles until eventually menopause is reached at 
50-51 years (Block, 1953; Gougeon and Chainey, 1987, Richardson et al., 1987, 
Forabosco et al., 1991; Faddy et al., 1992; Faddy and Gosden, 1996). 
Ovarian follicular dynamics and endocrine control in the bovine and human 
also resemble one another (Adams and Pierson, 1995; Baerwald et al., 2003). In vivo 
development of the primordial follicles to become pre-ovulatory follicles is seen to 
take similar amount of time in the human and the bovine (Gougeon, 1986; Lussier et 
al., 1987; Russe, 1983). The sizes of the ovarian follicles at each developmental stage 
are also within a similar range in both (Braw-Tal and Yossefi, 1997; Gougeon, 1996) 
(see figure 4.1), which indicates that there is a similar amount and rate of growth 
occurring in the ovarian follicles of both species as the ovarian follicles progress 
through the various stages of folliculogenesis. The bovine and the human have 
similar pathological conditions such as follicular cysts, luteinized anovulatory 
follicles, lactation- and stress- related suppression of follicle growth and ovulation 
(Adams and Pierson, 1995) and decreased fertility with maternal aging (Erickson et 
al., 1976; Klein and Sauer, 2001). These similarities not only in the reproduction and 
folliculogenesis of the bovine and human but also in pathological conditions indicate 
that the bovine would be a good model for the human. The aim of this chapter was 
therefore, to explore if the bovine was a good model for human primordial follicle 
activation in vitro, which will be achieved by using the in vitro two-step culture 
technique developed by McLaughlin and Telfer, 2010 and Telfer et al., 2008. This 
chapter will compare proportion of quiescent follicles activated and the subsequent 
growth of the ovarian follicles between the two species in vitro. 
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Figure 4.1 A Comparison of Ovarian Follicle Diameters at the Different 
Developmental Stages in the Bovine and Human during Early 
Folliculogenesis. This graph displays the increase in the diameters of the ovarian 
follicles in the bovine and the human through the progressive stages of 
folliculogenesis from the primordial stage to the early antral stage. At each stage of 
development the diameters of the ovarian follicles in the bovine and the human are 
similar (data from Gougeon, 1996 and Braw-Tal and Yossefi, 1997). 
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4.2 Materials and Methods 
 
4.2.1 Tissue Collection, Dissection and Culture 
 
Bovine ovaries were collected from the local abattoir from animals aged 
between 10-14 months (n=12) and transported to the laboratory in supplemented 
M199 medium. Human biopsies were collected from local hospitals after informed 
consent from women undergoing an elective caesarean section (n=10), and 
transported to the laboratory in human Leibovitz medium; for a full description see 
chapter 2. The cortex was extracted from 12 different bovine ovaries and human 
samples from 10 different women (see figure 4.2), and examined under a light 
microscope in bovine Leibovitz medium or human Leibovitz medium ensuring that 
all the ovarian follicles within the cortical strips were less than 40μm in diameter. 
These strips of cortex were then dissected to approximately 0.5-1 mm2 in size. Both 
the bovine and the human samples were cultured with bovine McCoy’s or human 
McCoy’s medium respectively for 6 days in a humidified incubator at 37°C and 5% 
CO2. Every 48hr the medium of both was changed by removing 150μl of the current 
medium and replacing it with 150μl of fresh control medium. After 6 days in culture 
the ovarian tissue was fixed, processed and H&E stained, for a full description see 









using a chi-square test. The change in the distribution of the ovarian follicle 
populations and the health of the different ovarian follicle populations between day 0 
and day 6 in bovine and the human repectively were compared using a chi-square 
test.  
Levels of activation, change in the ovarian follicle population, diameters of 
the quiescent follicles and primary follicles, the increase in the diameter of the 
ovarian follicles from quiesent to primary and the concentration of the ovarian 
follicles within the samples were tested for normal distribution using Kolmogorov 
Smirnoff test, further statistical tests were chosen based on whether the data was 
normal distributed or not. The level of activation and the increase in the proportion of 
ovarian follicles that were part of the primary and secondary follicle populations 
were calculated from day 0 to day 6 and were compared using a two-sampled t-test 
for both the bovine and the human. The average diameters of the quiescent and 
primary follicles in both the bovine and the human on both day 0 and day 6 were 
compared using a two-sampled t-test. The average increase in the diameter of the 
ovarian follicles and their oocytes from the quiescent to primary stage of 
development were compared using a two-sampled t-test within both species. The 
concentration of ovarian follicles in the bovine and human were compared using a 




4.3.1 Culture of the Human and Bovine Tissue In Vitro 
 
The activation of the quiescent follicles in the in vitro culture system were 
first explored individually in both human and bovine tissue by examining the 
changes in follicular distribution. Table 4.1 displays a summary of the data collected 
between the untreated day 0 samples and the cultured day 6 samples for both species.  
In both human and bovine there was a significant change in the distribution 
of the ovarian follicle populations (see figure 4.3). In the human at day 0 the 
distribution of the ovarian follicle populations showed that 63.62.6% comprised the 
quiescent follicle population, 33.31.9% comprised the primary follicle population 
and 2.81.4% comprised the secondary follicle population. After 6 days in culture 
the distribution of ovarian follicles was seen to change with a significant decrease in 
the quiescent population to only 36.24.4% of the ovarian follicle population 
(p<0.001) and a significant increase in both the primary follicle population to 
54.42.1% (p<0.001) and secondary follicle population to 9.4 2.9% (p<0.05) of the 
ovarian follicles population.  
In the bovine at day 0 the distribution of ovarian follicles showed that 
60.33.6% comprised the quiescent follicle population, 36.0 3.6% comprised the 
primary follicle population and 3.7 1.1% comprised the secondary follicle 
population. After 6 days in culture the distribution of the ovarian follicle populations 
changed with a significant decrease proportion of ovarian follicles in the quiescent 
follicle population to only 36.41.2% (p<0.001) of the ovarian follicle population 
and a significant increase in both the primary follicle population to 55.7 1.5% 
(p<0.001) and secondary follicle population to 7.9 0.9% (p<0.001) of the ovarian 
follicle population. 
The health of the ovarian follicles before and after being cultured in vitro 
were first explored individually in both human and bovine tissue. Table 4.2 displays 
a summary of the data collected between the untreated day 0 samples and the 
cultured day 6 samples for both species. For both human and bovine there was seen 
to be no significant difference in the proportion of healthy ovarian follicles in the 
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quiescent, primary or secondary follicle population between day 0 and day 6 
(p>0.05) (see figure 4.4). 
 







 Day 0 
Uncultured 




Day 6 Control 
Cultured 
No. Samples 10 10 12 12 
No. Follicles 178 209 353 345 
No. Quiescent 
Follicles 
108 75 205 125 
No. Primary 
Follicles 


































Table 4.2: Data Collected from Human and Bovine Samples used to 
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4.3.2 Comparing Human and Bovine Quiescent Follicle Activation and 
Growth within the In Vitro Culture System 
 
 In the human and the bovine the distribution of the ovarian follicles between 
at day 0 was seen to be similar with 63.64.2% and 59.65.5% quiescent (p>0.05), 
34.52.9% and 54.34.4% primary (p>0.05) and 1.91.0% and 2.01.3% secondary 
(p>0.05) in the human and the bovine respectively (see figure 4.3). The distribution 
of the ovarian follicles was also seen to be similar at day 6 in the human and bovine, 
with 36.25.2% and 36.34.9% quiescent (p>0.05), 54.34.4% and 55.82.9% 
primary (p>0.05) and 9.53.4% and 7.91.9% secondary (p>0.05) in the human and 
bovine respectively.  
The rate of activation was measured as a percentage change in the proportion 
of the ovarian follicles that were part of the growing follicle population from day 0 to 
after 6 days in culture. Between the human and the bovine there was a similar level 
of activation after 6 days in culture at 26.75.7% in the human and 23.54.3% in the 
bovine (p>0.05) (see figure 4.5 A).  
The activation of ovarian follicles led to an increase in the growing follicle 
population which consisted of both primary and secondary ovarian follicles. In both 
the human and bovine the populations of primary and secondary follicles increased 
by similar proportions (see figure 4.5 B). In the two species the primary follicle 
population increased after culture in vitro by 19.94.4% and 17.13.8% (p>0.05) in 
the human and bovine respectively. The secondary follicle population in both the 
bovine and human increased by similar amounts at 7.94.9% and 5.63.2% (p>0.05) 






4.3.3 Follicle Growth  
  
 The diameters of the quiescent and primary follicles were compared between 
day 0 and day 6 samples from both bovine and human. In the bovine the quiescent 
follicles had a mean diameter of 23.9 0.3m at day 0 (n=205) and 23.6 0.2m at 
day 6 (n=125) (p>0.05) and the primary follicles had a mean diameter of 29.1 
0.2m at day 0 (n=138) and 29.4 0.2m at day 6 (n=193) (p>0.05). In the human 
the quiescent follicles had a mean diameter of 35.7 0.2m at day 0 (n=108) and 
35.9 0.3m at day 6 (n=75) and the primary follicles in the human had a mean 
diameter of 45.2 0.3m at day 0 (n=63) and 45.6 0.2m at day 6 (n=112) (p>0.05). 
To examine the growth of the quiescent follicles to become primary follicles the 
mean increase in follicle diameter was compared between the human and the bovine. 
In the human there was a statistically larger increase in the diameter of the ovarian 
follicle from the quiescent to primary stage of development at 9.8 0.8m diameter 
increase compared to the bovine were there was a diameter increase of 5.5 0.6m 
(p<0.05) (see figure 4.6 A).  
 The diameter of the quiescent and primary follicle oocytes were compared 
between day 0 and day 6 from both bovine and human. In the bovine the quiescent 
follicle oocytes had a mean diameter of 20.2 0.2m at day 0 (n=205) and 20.3 
0.3m at day 6 (n=125) (p>0.05) and the primary follicle oocytes in the bovine had 
a mean diameter of 24.3 0.3m at day 0 (n=138) and 24.5 0.2m at day 6 (n=193) 
(p>0.05). In the human the quiescent follicle oocytes had a mean diameter of 33.6 
0.3m at day 0 (n=108) and 33.9 0.2m at day 6 (n=75) and the primary follicle 
oocytes in the human had a mean diameter of 37.9 0.3m at day 0 (n=63) and 38.1 
0.2m at day 6 (n=112) (p>0.05). To examine the growth of the oocytes in the 
quiescent follicles to become primary follicles the mean increase in oocyte diameter 
was compared between the human and the bovine. There was no statistical difference 
in the increase in the diameter of the oocyte between human and bovine from the 
quiescent to the primary stage of development at 4.6 0.3m and 4.2 0.3m 




4.3.4 Concentration of Ovarian Follicles 
 
 There was no significant difference in the concentration of ovarian follicles 
between the day 0 and day 6 samples in either the human or bovine (p>0.05) (see 
figure 4.7). However, there was a significantly higher concentration of ovarian 
follicles in the bovine with 148.419.5 ovarian follicles/ mm3 compared to the human 





The aim of this study was to establish if the bovine is a good model for 
human folliculogenesis in an in vitro culture system. This was achieved by culturing 
both human and bovine in vitro and comparing the level of activation, the changes in 
the proportion of the primary and secondary follicle populations and the increase in 
follicle and oocyte diameters of the quiescent and primary follicles between the 
bovine and human. The data showed that the culture system promoted the activation 
of the quiescent follicles to become growing follicles for both the bovine and the 
human and that the follicles maintained their health within the culture system, 
agreeing with the data in the Telfer et al 2008 and McLaughlin and Telfer 2010 
studies.  
In vivo the development of a quiescent follicles to become a secondary 
follicle is known to take up to 120 days in the human (Gougeon, 1986) and 160 in 
the bovine (Russe, 1983). Early follicular growth and development is thought to be 
extremely protracted (Telfer, 1998; Telfer and McLaughlin, 2011) however, it is 
unclear if the time taken in vivo is the definitive rate of the development for ovarian 
follicles or whether growth in vivo is modulated by local constraints. In this chapter a 
significant proportion of the quiescent follicles became part of the growing follicle 
population in both bovine and human after 6 days of culture. A significant number of 
quiescent follicles joining the growing follicle population have been previously 
observed in short term cultures in both the human (Telfer et al., 2008; Hovatta et al., 
1997; Wright et al., 1999) and the bovine (McLaughlin and Telfer, 2010; Wandji et 
al., 1996b), suggesting that activation occurs as a result of a release of intraovarian 
factors that normally inhibit the activation (Adikari and Liu, 2009; Wandji et al., 
1998). One cause could be the removal of the medulla, as the medullary region of the 
ovary is thought to secrete inhibitory factors to slow down ovarian follicle growth 
(Fortune et al., 2000), highlighted by activation in the whole ovarian cultures being 
more limited in comparison to the ovarian strips where the medulla has been 
removed (Eppig, 1996; Wandji et al., 1996b). Another factor could be disruption of 
Hippo signalling. Hippo signalling pathway is important in maintaining optimal 
organ size (Pan, 2007; Halder and Johnson, 2011, Hergovich, 2012). Dissecting the 
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tissue into smaller pieces in the murine ovaries promoted actin polymerization that 
disrupts Hippo signalling, which resulted in an increased expression of down stream 
growth factors and the promotion of follicular growth (Kawamura et al., 2013). 
Therefore, dissecting the human and bovine ovarian sample into small fragments 
could be disrupting the Hippo signalling resulting in follicle growth and thereby an 
increase in the proportion of ovarian follicles becoming part of the growing follicle 
population.  
The activation of the primordial follicles causes a change in the ovarian 
follicle’s morphology, characterised by the enlargement of its oocyte and the 
flattened granulosa cells becoming cuboidal as they transform into primary follicles 
(McGee and Hsueh, 2000; Picton, 2001). The bovine and the human 
characteristically have approximately the same range of ovarian follicle diameters for 
each of the different developmental stages (see figure 4.1) (Braw-Tal and Yossefi, 
1997; Gougeon, 1996), suggesting that the ovarian follicles must grow roughly by 
the same amount as they transition between various stages of folliculogenesis. 
However, in this study it was observed that the human ovarian follicles had a larger 
percentage increase in diameter from quiescent stage to the primary stage of 
development compared to the bovine, indicating that human ovarian follicles 
undergo more growth to reach the primary stage from the quiescent stage of 
development. However, this difference could be due to the varying levels of 
primordial and transitional follicles within the quiescent follicle populations of the 
two species. The majority of the quiescent follicles population in the bovine model 
are transitional follicles (vanWezel and Rodgers, 1996b), whereas in the human the 
transitional population only makes up only half of the quiescent follicle population 
(Gougeon and Chainy, 1987). Therefore, the difference in the percentage increase in 
the diameter of the ovarian follicles could be attributed to the varying number of 
cuboidal granulosa cells, which are larger in size in comparison to the flatter 
granulosa cells. The difference in the proportion of the primordial and transitory 
follicles within the two species could therefore, be influencing the observed increase 
of the ovarian follicle diameter during the transition between the quiescent and 
primary stages of development.  
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Between the human and the bovine the oocyte is also seen to be similar in 
diameter at each stage of ovarian follicle development (Braw-Tal and Yossefi, 1997; 
Gougeon, 1996). Therefore, to remove the impact of the different proportions of 
primoridal or tranisitory follicles in the quiescent follicle population in the bovine 
and human, the oocytes of both the quiescent follicles and primary follicles were 
examined. The oocytes were examined to see if there was a difference in the oocyte 
diameter during the transition between the quiescent and primary stage of 
development in the bovine and human. It was observed that the oocyte diameter in 
both the human and the bovine increased by a comparable amount from the quiescent 
to the primary stage of development, indicating that a similar amount of growth must 
occur in the oocyte during this transition from the quiescent to the primary stage of 
development in both species.  
The distribution of the ovarian follicles is known to vary widely in the ovary 
with around 90% of the ovarian follicles found within the cortex, and even within 
this region the ovarian follicles are not evenly distributed (Jimenez, 2010; vanWezel 
and Rodgers, 1996), therefore, it is important to note that the concentrations of the 
ovarian follicles seen in figure 4.7 are based on the follicle concentration in the 
cortex rather than the ovary as a whole. However, as it is the cortex that is utilised in 
both fertility preservation (von Wolff et al., 2009) and in vitro research examining 
primordial follicles (Braw-Tal and Yossefi, 1997; McLaughlin and Telfer, 2010; 
Telfer et al., 2008; Wandji et al., 1996a; Wandji et al., 1997) in species where 
culturing the whole ovary is not possible due to its large size (Telfer et al., 2000; 
Thomas et al., 2003; Wandji et al., 1996b), comparing the cortex of the two species 
is beneficial in determining if the bovine is a good model for the human follicle 
activation in vitro. The concentration of ovarian follicles within the cortex is much 
higher in the ovarian samples from the bovine than those from the human. This 
difference in concentration can be attributed to the difference in the age at which the 
samples were collected from the two species. Age is an important factor in 
determining the number of ovarian follicles left within the ovary, as the number 
declines with increasing age as the primordial follicles are activated (Erickson, 1966, 
Gosden and Telfer, 1987a; Gosden and Telfer, 1987b; Wallace and Kelsey, 2010). It 
has previously been observed that ovarian tissue collected from women over the age 
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of 30 have a much lower density of primordial follicles in comparison to younger 
ages which makes them less useful for testing a range of concentrations within drug 
treatments or optimising conditions (Cortvrindt and Smitz, 2001b; Lass et al., 1997). 
Caesarean section patients are the most abundant source of ovarian samples for 
analysis in our laboratory, and are generally above the age of 25. Using the bovine 
with its higher concentration of primordial follicles would be beneficial, as a model, 
to optimise the culture conditions or to select drug treatment concentrations before 
testing it in the human to ensure that the human tissue is used in the best way.  
The evidence from this study indicates that the bovine is a good model for 
human primordial follicle activation and subsequent growth in an in vitro culture 
system. This is due to a number of similarities seen between the two species 
including comparative levels of activation and subsequent increases in the primary 
and secondary follicle populations. There was also seen to be a similar amount of 
growth required for the both to progress from quiescent to the primary stage of 
development observed in the diameter of the oocyte. The higher concentration of 
ovarian follicle in the bovine samples makes the bovine a good model, as this will 
allow the culture conditions and selected drug treatment concentrations to be 
































It is widely accepted that the female’s entire store of oocytes is formed in 
fetal or early life dependent on the species, with no additional oocytes created in later 
life (McGee and Hsueh, 2000; Zuckerman, 1951). The store of mammalian oocytes 
is held in an immature and dormant state as primordial follicles (Escobar et al., 2011; 
McGee and Hsueh, 2000). In order for mature oocytes to be produced the primordial 
follicles must be activated to undergo folliculogenesis. Folliculogenesis is the 
process of ovarian follicle development in which a recruited primordial follicle 
grows and develops until it reaches a point where the oocyte can be matured (Binelli 
and Murphy, 2010; McGee and Hsueh, 2000). Activation of primordial follicles is 
irreversible so once activated each follicle will continue through the various stages of 
folliculogenesis or undergo atresia (Elvin and Matzuk, 1998). The female’s 
reproductive lifespan is therefore, dependent on the number of dormant primordial 
follicles remaining within the ovary and so the loss of the primordial follicles from 
the dormant pool through activation must be tightly controlled or the individual will 
undergo POI. 
The mechanisms involved in controlling primordial follicle activation are still 
unclear, however a number of different studies have highlighted a range of factors 
that appear to play a role (Adhikari et al., 2013; Kim, 2012; Monget et al., 2012; 
Pangas, 2012; Reddy et al., 2010). Many of these factors are part of the PI3K 
pathway, for example Pten (Reddy et al., 2008), Foxo3 (John et al. 2008, Castrillon 
et al 2003, Liu et al., 2007), Pdk1 and rps6 (Reddy et al., 2009) (see figure 5.1). This 
pathway is known to play an important role in cellular survival, growth and 
proliferation through a variety of downstream mechanisms (Cantley, 2002; Stokoe, 
2005) and is considered to be one of the key pathways involved in both primordial 
follicle activation and maintaining the dormancy of the primordial follicle pool 
(Castrillon et al., 2003; John et al., 2008; Li et al., 2010; Liu et al., 2007; 





Figure 5.1: The PI3K Pathway. This diagram displays the details of the different 
factors that are involved in PI3K pathway and each of the key phosphorylation steps 
that occur during the stimulation of the PI3K pathway. These factors include Pten, 
Foxo3, Pdk1 and rps6 all of which have been shown in previous studies to play a role 
in controlling primordial follicle activation and maintaining the dormancy of the 
primordial follicle pool.  
 
The Reddy et al., 2008 and Reddy et al., 2009 studies are good examples for 
demonstrating the role of the PI3K pathway in primordial follicle activation and 
dormancy. The Reddy et al., 2008 study deleted the Pten gene from the oocytes of 
mice by crossing PtenloxP/loxP mice (Groszer et al., 2001) with transgenic mice 
expressing Gdf-9 promoter-mediated Cre recombinase (Lan et al., 2004). Pten 
negatively regulates the PI3K pathway by converting PIP3 back into PIP2 (Cantley, 
2002), without it there is an up-regulation of the PI3K pathway. In the oocyte-
specific Pten knockout mouse model there was an increase in primordial follicle 
activation so by PD8 only 49.6% of the ovarian follicles were primordial in 
comparison to 83.6% of the ovarian follicles being primordial in the wild type mice. 
Consequently, by PD35 there were virtually no primordial follicles left in the ovary 
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in the oocyte-specific Pten knockout mice (Reddy et al., 2008) (see figure 5.2) 
demonstrating the consequence of widespread primordial follicle activation. The 
Reddy et al., 2009 study deleted Pdk1 from the oocytes of mice by crossing 
Pdk1loxP/loxP mice (Hashimoto et al., 2006, Inoue et al., 2006) with transgenic mice 
expressing Gdf-9 promoter-mediated Cre recombinase (Lan et al., 2004). Pdk1 is 
required to co-bind with PIP3 to activate Akt thereby activating the downstream 
components of the PI3K pathway (Engelman et al., 2006; Mora et al., 2004); without 
it there is a down regulation of the PI3K pathway. By PD35 only 33.7% of the total 
number of ovarian follicles observed in the wild type ovary were found in the 
oocytes-specific Pdk1 deficient mice and only 61.6% of the proportion of growing 
follicles (Reddy et al., 2009). This shows a decrease in primordial follicle activation 
and the loss of the primordial follicles directly from the primordial follicle pool 
highlighting their inability to maintain their dormant state. 
 
           
  
Figure 5.2: Role of the PI3K pathway in Primordial Follicle Activation 
and Dormancy. This figure displays the impact of changing the level of PI3K 
within the ovary representing the data found within the previous mouse studies. 
When the PI3K pathway is down regulated the ovary becomes smaller in size due to 
it predominately having only quiescent follicles. Contrastingly, when the PI3K 
pathway is up regulated the ovary becomes larger due to the increased number of 
activated follicles, which have begun to grow and are therefore, are much larger in 
size. 
 
 The role of the PI3K pathway in primordial follicle activation has mainly 
been explored by using knockout mouse models (Castrillon et al., 2003; John et al., 
2008; Liu et al., 2007; Rajareddy et al., 2007; Reddy et al., 2009; Reddy et al., 2008) 
therefore, it is important to establish whether it has the same role in other species. 
Recently, two pharmacological compounds 740 Y-P and bpV (HOpic) have been 
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shown to be able up-regulate the PI3K pathway. This has allowed the PI3K pathway 
to be explored in species where it is not possible to use a knockout model (Li et al., 
2010; McLaughlin et al., 2014). 740 Y-P binds to the SH2 domain of the p85 
regulatory subunit of PI3K inhibiting its inhibition of p110 thereby, stimulating the 
activity of p110 causing an up-regulation of the PI3K pathway (see figure 5.3) 
(Derossi et al., 1998). bpV (HOpic) binds to PTEN inhibiting its ability to convert 
PIP3 back into PIP2 again resulting in an up-regulation of the PI3K pathway (Bevan 
et al., 1995; Li et al., 2010; Posner et al., 1994; Schmidt et al., 2004). 740 Y-P and 
bpV (HOpic) caused a similar increase in primordial activation in the mouse model 
to the knockout mouse models where PI3K pathway had been up regulated (Li et al., 
2010). 
The role of the PI3K pathway has been explored in the human using bpV 
(HOpic) (Li et al., 2010; McLaughlin et al., 2014); these studies demonstrate an 
increase in primordial follicle activation but resulted in a decrease in follicle survival. 
However, there is still much we do not know about the role of the PI3K pathway in 
large mono-ovulatory species like the human. This study will explore the hypothesis 
that in the bovine model, both bpV (HOpic) and 740 Y-P will cause an up-regulation 
of the PI3K pathway thus causing increased primordial follicle activation, as 
observed in both the mouse and human models (Li et al., 2010; McLaughlin et al., 
2014). This chapter aims to examine the role of the PI3K pathway on follicle 
activation, health and development, using both bpV (HOpic) and 740 Y-P in a range 
of concentrations and to explore the impact of different levels of stimulation and the 
way the PI3K pathway is up-regulated on the ovarian follicle population. 
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Figure 5.3: Interactions of 740 Y-P and bpV (HOpic) with the PI3K 
pathway. 740Y-P binds to the p85 subunit of PI3 kinase to inhibit its inhibition of 
p110 thereby, increasing the catalytic activity of p110. bpV (HOpic) inhibits PTEN 
preventing it from converting PIP3 back into PIP2. Both cause the up-regulation of 
the PI3K pathway resulting in increased levels of phosphorylated Akt and thereby 
increased primordial follicle activation. 
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5.2 Materials and Methods 
 
5.2.1 Tissue Collection and Dissection 
 
Bovine ovaries were collected from local abattoir from animals aged between 
10-14 months and transported to the laboratory in supplemented M199 medium. 
Strips of the cortex were removed from the ovaries to a depth of 1-2mm. The strips 
were examined under a light microscope in bovine Leibovitz to ensure that all the 
ovarian follicles within them were less than 40μm in diameter. These cortical strips 
were then dissected to approximately 0.5-1 mm2 in size (as described in chapter 2). 
 
5.2.2 Exploring the Levels of Akt and p-Akt 
 
5.2.2.1 Tissue Treatment 
 
Dissected cortical strips (see section 5.21) were cultured for 24 hours in 
bovine McCoy’s (see figure 5.4). All medium was then removed and the cortical 
strips were treated with either fresh bovine McCoy’s, bovine McCoy’s with 10µM 
bpV (HOpic) or bovine McCoy’s with 100µg/ml 740 Y-P for 15 minutes (see figure 







Figure 5.4: Tissue Collection for Western Blotting. a) Strips of the cortex 
were taken from the bovine ovaries and b) examined to ensure all ovarian follicles 
were less than 40μm in diameter. c) All cortical strips were incubated in bovine 
McCoy’s for 24 hours. The cortical strips were then d) treated with bovine McCoy’s 
or bovine McCoy’s with either bpV(HOpic) or 740 Y-P for 15 minutes. All cortical 
strips were then immediately e) snap frozen for protein extraction and western 
blotting. 
 
5.2.2.2 Protein Extraction and Western Blotting 
 
Protein was extracted using a hand held homogeniser in RIPA buffer which 
consisted of 25mM Tris HCl, 150mM NaCl, 1% Triton x-100, 0.1% SDS and 0.05% 
sodium deoxycholate. For every 10ml of RIPA buffer 1 mini-complete protease 
inhibitor cocktail tablet and 1 mini-phospho-STOP tablet was added (Roche Products 
Limited, Welwyn Garden City, UK). Once homogenised the samples were spun at 
14000g for 10 minutes in a centrifuge. The concentration of protein within each 
sample was established by comparing its absorbency to standard BSA (Thermo 
Fisher Scientific, Hemel Hempstead, UK) concentrations of 1mg/ml, 0.5mg/ml, 
0.25mg/ml, 0.125mg/ml and 0mg/ml. Each assay contained 5l of a 1/10 dilution of 
the sample or BSA concentrations along with 25l of Reagent A*; which consists of 
20l of Reagent S to every 1ml of Reagent A, and 200l of Reagent B, all reagents 
are from a western blotting kit from Corning Costar Europe, in a flat bottomed clear 
96-well plate (Corning Costar Europe). All samples had three repeats. The samples 
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were placed on a plate shaker at room temperature for 15 minutes, and then the 
absorbance measured at 590nm on a plate reader. Concentrations of the protein 
samples were calculated by comparing their absorbencies against the absorbencies of 
the known BSA standard concentrations.    
For each treated piece of tissue two protein samples were used. The protein 
samples were prepared so each sample contained 20g of protein plus RIPA buffer 
to give a total volume of 20l. Each sample also contained 5l of SDS Sample 
Buffer consisting of 6.25 Tris with 5% glycerol, 2% SDS and 10% water and 10% -
mercaptoethanol. Samples were heated to 99C for 6 minutes then cooled on ice. 
Each sample was then loaded into individual pre-packed 4-20% gels (Thermo Fisher 
Scientific) alongside 5µl Page Ruler Plus ladder (Thermo Fisher Scientific, Hemel 
Hempstead, UK). The loaded gels were run in 1Tris-HEPES SDS Buffer (Thermo 
Fisher Scientific) at 125V for 1 hour. Immobilon FL blotting paper (one per gel) 
(Merck Millipore, Nottingham, UK) was rinsed in methanol for 30 seconds then 
water for 1 minute and finally 1 Semi-Dry Fast Transfer Buffer (Thermo Fisher 
Scientific) for 15 minutes. Two pieces of blotting paper were cut per gel and soaked 
in the 1 Semi-Dry Fast Transfer Buffer before being use. The gel and Immobilon 
FL blotting paper were sandwiched between two pieces of blotting paper in a Pierce 
Fast Semi-Dry Blotter unit (Thermo Fisher Scientific) for 9 minutes at 25V.  
The Immobilon FL blotting paper now with the protein on it (from here on 
referred to as the blot) was rinsed in water (2 × 5 minutes) then washed with 
phosphate buffered saline with 0.1% Tween (PBST) (4 × 5 minutes). The blot was 
then placed in a block solution consisting of a 1:1 solution of blocking buffer 
(Rockland Immunochemicals Inc. PA, USA) and 0.1% PBST at room temperature. 
After this the blot was incubated with a rabbit polyclonal antibody raised against 
either Akt (9272) or pAkt (9271) (Cell Signalling, Hitchin, Hertfordshire, UK) both 
diluted to 1:1000 and a mouse monoclonal antibody raised against -actin (A5441) 
(Sigma-Aldrich) diluted to 1:3000. The primary antibodies were left on the 
membrane in a cold room at 4C overnight. The blot was then washed in 0.1% PBST 
(4 × 5 minutes), then incubated with a polyclonal donkey antibody raised against 
rabbit IgG (heavy and light chain) conjugated with Alexa Fluor680 (Invitrogen, 
Paisley, UK) and a donkey polyclonal antibody raised against mouse IgG (heavy and 
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light chain) conjugated with IRDye8000 (Rockland Immunochemical) both diluted 
to 1:10000 for an hour at room temperature. Before scanning the blot was washed in 
0.1% PBST (2 × 5 minutes) then in 0.1% PBS (2 × 5 minutes). The membrane was 
then scanned using a LI-COR Odyssey Infrared Imagine device (LI-COR 
Biosciences UK Ltd, Cowley Road, Cambridge, UK) to detect the fluorescent bands 
and calculate the concentration of each band for analysis.  
 
5.2.3 Bovine Tissue Culture 
 
Dissected cortical strips (see section 5.21) were treated with bovine McCoy’s 
or bovine McCoy’s with 1µM, 10µM or 100µM of bpV (HOpic) or 0.1µg/ml, 
1µg/ml, 10µg/ml or 100µg/ml of 740 Y-P in a humidified incubator at 37°C with 5% 
CO2 for 24 hours (see figure 5.5). After 24 hours all the medium was removed and 
replaced with bovine McCoy’s medium only for a further 6 days, with a medium 
change every 48 hours. The bovine ovaries were then fixed in formalin, processed 
and placed onto slides for H&E staining (as described in chapter 2).  
 
 
Figure 5.5: Tissue Culture Method. a) Strips of the cortex were dissected from 
the ovary. b) These cortical strips were further dissected so all ovarian follicles were 
less than 40μm in diameter. Cortical strips were then treated with c) bovine McCoy’s 
or bovine McCoy’s with varying concentrations of bpV (HOpic) and 740 Y-P for 24 
hours. d) All the medium was then removed and tissue was cultured for a further 6 
days with bovine McCoy’s medium only. 
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5.2.4 Analysis  
 
 The western blot data was analysed by initially normalising the Akt and p-
Akt bands against the -actin band. The levels of Akt that had been phosphorylated 
could thus be established within each sample and compared between the tissue 
treated with bovine McCoy’s to tissue treated with either bovine McCoy’s with bpV 
(HOpic) or bovine McCoy’s with 740 Y-P.  
Ovarian cortical samples were H&E stained for morphological analysis. The 
morphology of the ovarian follicles allowed for each of them to be classified as 
either quiescent, which included the primordial and transitory follicles, or as primary 
or secondary follicles. Each ovarian follicle was classified as healthy or unhealthy, 
again based on morphology. Ovarian follicles were also measured using light 
microscopy with an eyepiece graticule. The ovarian follicle concentration was 
calculated using ImageJ 1.44g (Rasband W.S, National Institutes of Health, USA, 
http://imagej.nih.gov/ij/). Full parameters for classification of the ovarian follicles 
developmental stages, follicular health and calculation of concentration can be seen 
in chapter 2. 
 
5.2.5 Statistical Analysis 
 
  Kolmogorov Smirnoff test was used to test for normal distribution of data, 
further statistical tests were chosen based on whether the data was normal distributed 
or not. The bpV (HOpic) and 740 Y-P treatment groups were collected separately 
with their own control, for both treatments 3 samples were collected from three 
different experiments to explore the level of Akt and p-Akt (n=3). The levels of 
phosphorylated Akt were compared between tissue treated with bovine McCoy’s 
with tissue treated with either bovine McCoy’s with bpV (HOpic) or bovine 
McCoy’s with 740 Y-P using a two-sampled t-test.  
The bovine tissue culture was repeated 4 times for the different treatments 
with both bpV (HOpic) or 740 Y-P. Each set of experiments for bpV (HOpic) and 
740 Y-P where run seperately with a uncultured and control samples taken for each 
set of experiments. A total of 24 cortical strips were collected from these 4 
experiments for each treatment group (n=24). The number of ovarian follicles within 
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each cortical strips varied between 11-68, with an average of 30 folicles per cortical 
strip. The uncultured and the control the samples from the separate bpV (HOpic) and 
740 Y-P experiments were compared both seperately (n=24) and together (n=48). 
The distribution of the developmental stages of the ovarian follicles in each cortical 
strip was compared between the different treatment groups using a chi-square test. 
The health of the ovarian follicles within each developmental stage in each cortical 
strip was also compared using a chi-square test.  
In order to compare the concentration of ovarian follicles within the different 
treatment groups the data were first tested for normal distribution using Kolmogorov 
Smirnoff test. The data was shown to be normally distributed therefore, a two-
sampled t-test was used to compare the concentration of ovarian follicles between the 
uncultured tissue samples and control cultured tissue samples within each cortical 
strip, with the uncultured to the control the samples from the separate bpV (HOpic) 
and 740 Y-P experiments being compared both separately (n=24) and together 
(n=48). The concentration of the ovarian follicles was compared between the control 
samples and sample exposed to various concentrations of bpV (HOpic) or 740 Y-P 
using one-way ANOVA, where this test reported a significant difference the groups 
were compared individually using a post hoc Tukey test.  
To compare the diameter of the ovarian follicles and oocytes from the 
different stages of follicular development both were first tested for normal 
distribution using a Kolmogorov Smirnoff test. The Kolmogorov Smirnoff test 
revealed the data to be normally distributed therefore, the diameter of the ovarian 
follicles within each developmental stage and their oocytes was compared between 
the uncultured and the control tissue using a two-sampled t-test. The diameter of the 
ovarian follicles within each developmental stage and their oocytes was compared 
between the control and the various concentrations of either bpV (HOpic) or 740 Y-P 
using a one-way ANOVA, where this test reported a significant difference the groups 





5.3.1.2 The Level of Akt of Phosphorylation after Treatment with bpV 
(HOpic) and 740 Y-P Phosphorylation 
 
The levels of total Akt and Akt that had been phosphorylated were compared 
between the tissue exposed to either bovine McCoy’s with bpV (HOpic) (n=3) or 
740 Y-P (n=3) to tissue treated with only bovine McCoy’s (from here on refered to 
as the control) for 15 minutes. The level of total Akt was seen to be similar between 
those treated with control, bpV (HOpic) or 740 Y-P, however, there was a significant 
increase of phosphorylated Akt of 2.5 0.3 fold after exposure to bpV in comparison 
to the control (HOpic) (p<0.05) (see figure 5.6). Similarly, exposure to 740 Y-P 
caused a significant 2.1 0.4 fold increase in the level of phosphorylated Akt in 







5.3.2 Follicular Distribution after Treatment with bpV (HOpic) and 740 Y-
P  
  
The follicular distribution within the cortical strips was examined after 
treatment with both bpV (HOpic) and 740 Y-P and compared to the control group. 
Table 5.1 displays a summary of the data collected from the different treatment 
groups. Firstly the distribution of the developmental stages of the ovarian follicles 
were anaylsed between uncultured tissue and tissue cultured in control medium. The 
quiescent follicle population decreased significantly from 58.3 0.9% in the 
uncultured samples to only 36.9 0.8% in the cultured control samples (p<0.001). 
The primary follicle population significantly increased from 39.8 1.0% in the 
uncultured tissue to 56.90.8% in control cultured tissue (p<0.001). The secondary 
follicle population significantly increased from 1.90.4% in the uncultured tissue to 
6.20.4% in control cultured tissue (p<0.001) (see figure 5.8). 
 There was a change in the distribution of the developmental stages of the 
ovarian follicle populations when comparing the ovarian tissue samples cultured in 
control medium to those treated in medium containing various concentrations of bpV 
(HOpic) (see figure 5.9). In control 36.11.2% of the ovarian follicles were quiescent 
which is significantly higher than those treated with bpV (HOpic) at 26.51.0%, 
25.51.3% and 26.01.0% in 1µM, 10µM and 100µM bpV (HOpic) respectively 
(p<0.001). No significant difference was seen in the population of quiescent follicle 
between the different concentrations of bpV (HOpic) (p>0.05). In the control tissue 
57.51.2% of the ovarian follicles were primary follicles; there was a significant 
increase in the proportion of primary follicles when treated with bpV (HOpic) to 
69.61.2%, 66.51.7% and 66.71.0% in 1µM, 10µM and 100µM bpV (HOpic) 
respectively (p<0.001). Again no significant difference was observed in the 
population of primary follicles between any of the bpV (HOpic) treatment groups 
(p>0.05). No significant different in the proportion of secondary follicles was 
observed in the control, 1µM, 10µM and 100µM bpV (HOpic) treatment groups 
(p>0.05). 
 A comparison the ovarian tissue culture in control medium in to those treated 
with medium containing various concentrations of 740 Y-P displayed that there was 
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a difference in the distribution of the developmental stages of the ovarian follicle 
populations (see figure 5.10). The control group had a significantly higher proportion 
of quiescent follicles at 37.71.1% in comparison to those treated with 740 Y-P at 
26.61.5%, 25.61.1%, 22.61.5% and 19.31.5% in 0.1g/ml, 1g/ml, 10g/ml 
and 100g/ml 740 Y-P (p<0.001). No significant difference was seen in the various 
concentrations of 740 Y-P (p>0.05). The control group had a significantly lower 
proportion of primary follicles at 56.11.0% in comparison to 66.70.8%, 
68.31.0%, 72.10.7% and 74.91.5% in 0.1g/ml, 1g/ml, 10g/ml and 100g/ml 
740 Y-P (p<0.001). Again no significant difference was seen in the various 
concentrations of 740 Y-P (p>0.05), although there does appears to be a trend 
towards a dose-dependent increase in activation with an increase in the concentration 
of 740 Y-P. No significant difference was observed in the proportion of secondary 
follicles between the control, 0.1g/ml, 1g/ml, 10g/ml and 100g/ml 740 Y-P 
treatment groups (p>0.05).  
Table 5:1 Data collected from the different treatment groups to calculate the 





























Uncultured 24 748 422 312 14 
Control 24 760 276 438 46 
1M bpV 
(HOpic) 
24 691 180 483 28 
10M bpV 
(HOpic) 
24 677 176 451 50 
10M bpV 
(HOpic) 






Uncultured 24 713 424 277 12 
Control 24 943 354 530 59 
0.1 g/ml 
740 Y-P 
24 716 191 482 43 
1 g/ml 
740 Y-P 
24 702 182 481 39 
10 g/ml 
740 Y-P 
24 681 149 496 36 
100 g/ml 
740 Y-P 







5.3.3 The Health of the Ovarian Follicle Populations and Concentration 
of the Ovarian Follicles within the Cortical Strips after Treatment with 
bpV (HOpic) and 740 Y-P 
 
The health of the ovarian follicle populations were examined after treatment 
with both bpV (HOpic) and 740 Y-P and compared to the control group. Table 5.2 
displays a summary of the data collected from the different treatment groups. 
Between the uncultured tissue and tissue cultured with control medium there was 
seen to be no significant difference in the proportion of healthy of the quiescent, 
primary or secondary follicles, with 67.91.9%, 66.11.8% and 60.25.9% of the 
quiescent, primary and secondary follicles seen to be healthy in the uncultured 
samples compared to 66.21.2%, 67.01.1% and 57.85.0% of the quiescent, 
primary and secondary follicles seen to be healthy in the control cultured samples 
(p>0.05) (see figure 5.11). No significant difference was observed in the 
concentration of the ovarian follicles within the cortical strips at 154.34 11.4 
ovarian follicles per mm3 in the uncultured samples compared to 160 13.8 ovarian 
follicles per mm3 in the control cultured samples (p>0.05). 
 The health of the quiescent follicles was impacted by treatments with both 
bpV (HOpic) and 740 Y-P. Treatment with bpV (HOpic) led to the proportion of 
healthy quiescent follicles decreasing from 66.41.9% in control to 45.23.0%, 
40.92.9%, 14.82.2% in 1M, 10M and 100M bpV (HOpic) respectively in a 
dose-dependent manner (p<0.05) (see figure 5.12). After treatment with 740 Y-P 
there was a decrease in health in the quiescent follicles from 66.01.6% in the 
control to 52.72.7%, 49.62.3%, 40.14.9%, 37.23.9% in 0.1g/ml, 1g/ml, 
10g/ml and 100g/ml 740 Y-P respectively, with a significant reduction in the 
health at the two highest concentration of 740 Y-P in comparison to the two lowest 
concentrations of 740 Y-P (n=24) (p<0.01) (see figure 5.13). 
 Similarly, the health of the primary follicle populations decreased after 
treatment with both bpV (HOpic) and 740 Y-P. With the primary follicle health 
decreasing from 68.81.5% in the control to 27.31.5%, 23.51.6% and 9.31.4% in 
1M, 10M and 100M bpV (HOpic) respectively in a dose-dependent manner 
(p<0.05) (see figure 5.14). After treatment with 740 Y-P the health of the primary 
 129 
follicles decreased from 65.21.5% in the control to 41.71.2%, 38.51.0%, 
25.41.5% and 23.9±1.3% in 0.1g/ml, 1g/ml, 10g/ml and 100g/ml 740 Y-P 
respectively, with a further significant decrease in health at the two higher 
concentrations of 740 Y-P compared to the two lower concentrations of 740 Y-P 
(p<0.01) (see figure 5.15). 
 The health of the secondary follicle population was also compared between 
the controls and the various treatment groups of bpV (Hopic) and 740 Y-P. No 
significant difference was observed in the health of the secondary follicles population 
between the different treatment groups (p>0.05) (see figure 5.16).  
No significant difference was observed in the concentration of ovarian 
follicles in the control group and the tissue treated with the various different 
concentrations of bpV (HOpic) or 740 Y-P (p>0.05) (see figure 5.17). 
 
Table 5.2 Data collected from each treatment group used to calculate 


























































































































Uncultured  24 294 128 198 114 9 5 
Control 24 182 94 301 137 26 20 
1M bpV 
(HOpic) 
24 81 99 131 352 16 12 
10M bpV 
(HOpic) 
24 68 108 106 345 30 21 
10M bpV 
(HOpic) 







Uncultured  24 283 141 186 91 6 6 
Control 24 236 118 344 186 35 24 
0.1 g/ml 
740 Y-P 
24 99 92 198 284 21 22 
1 g/ml 
740 Y-P 
24 88 94 185 296 20 19 
10 g/ml 
740 Y-P 
24 51 98 125 371 19 17 
100 g/ml 
740 Y-P 





Figure 5.11: A Comparison of Follicular Health and Concentration of 
Follicles between the Uncultured Tissue Compared with the Control 
Cultured Tissue. There was no significant decrease in the a) health of the 
quiescent, primary or secondary follicles in the uncultured tissue in comparison to 
the control cultured tissue (p<0.05). No significant difference was seen in b) the 
concentration of the ovarian follicles found in the uncultured tissue in comparison to 













5.3.4 Follicle and Oocyte Diameters after Treatment with bpV (HOpic) 
and 740 Y-P 
 
 No significant difference was observed in the size of the quiescent follicles or 
their oocyte between the uncultured (n= 846) and control cultured group (n=630) 
(p>0.05). However, tissue treated with bpV (HOpic) had an increase in the diameter 
of the quiescent follicles to a mean diameter of 26.10.2m, 28.90.3m and 
27.50.2m in 1M (n=180), 10M (n=176) and 100M (n=153) bpV (HOpic) 
compared to 24.00.1m in the control (n=276) (p<0.001) (see figure 5.18 and 5.19). 
The oocytes within the quiescent follicles also increased in diameter from 
20.70.1m in the control (n=276) to 21.60.2m, 24.10.2m and 22.80.2m in 
1M (n=180), 10M (n=176) and 100M (n=153) bpV (HOpic) (p<0.001) (see 
figure 5.18 and 5.19).  
Similarly, the diameters of the quiescent follicles increased after treatment 
with 740 Y-P. The quiescent follicles had a mean diameter of 23.90.2m in the 
control (n=354) whereas, those treated with 740 Y-P had a mean diameter of 
26.60.2m, 28.40.2m, 31.80.3m and 29.60.3m in 0.1g/ml (n=191), 
1g/ml (n=182), 10g/ml (n=149) and 100g/ml (n=144) 740 Y-P (p<0.001) (see 
figure 5.18 and 5.18). The oocytes within the quiescent follicles had a mean diameter 
of 22.20.2m, 23.80.2m, 27.50.3m and 25.70.2m in 0.1g/ml (n=191), 
1g/ml (n=182), 10g/ml (n=149) and 100g/ml (n=144) 740 Y-P in comparison to 
20.50.2m in the control (n=354) (p<0.001) (see figure 5.18 and 5.19). 
 No signifcant difference was observed in the size of the primary follicles or 
their oocytes between the uncultured (n=589) and control cultured ovarian tissue 
(n=968) (p>0.05). However, treatment with bpV (HOpic) resulted in an increase in 
the mean primary follicle diameter in comparison to the control (n=438) at 
28.90.1m in diameter compared to 30.40.1m, 32.20.1m and 30.80.1m in 
1M (n=483), 10M (n=451) and 100M (n=384) bpV (HOpic) respectively 
(p<0.001) (see figure 5.20 and 5.21).  
The oocytes within the primary follicles increased from a mean diameter of 
23.50.1m in the control (n=438) to 24.80.1m, 26.30.1m and 25.10.1m in 
1M (n=483), 10M (n=451) and 100M (n=384) bpV (HOpic) (p<0.001) (see 
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figure 5.20 and 5.21). Treatment with 740 Y-P also caused an increase in the mean 
diameter of the primary follicles with the control (n=530) at 28.60.1m in 
comparison to 31.60.1m, 34.00.1m, 34.70.1m and 34.6 0.1m in 0.1g/ml 
(n=482), 1g/ml (n=481), 10g/ml (n=496) and 100g/ml (n=491) 740 Y-P 
(p<0.001) (see figure 5.20 and 5.21). The oocytes within the primary follicles had a 
mean diameter of 22.20.2m, 23.80.2m, 27.50.3m and 25.70.2m in 
0.1g/ml (n=482), 1g/ml (n=481), 10g/ml (n=496) and 100g/ml (n=491) 740 Y-
P in comparison to 20.50.2m in the control (n=530) (p<0.001) (see figure 5.20 and 
5.21). 
 No significant difference was observed in the diameter of the secondary 
follicles or their oocytes between the uncultured (n=26) and control cultured ovarian 
tissue (n=105). No significant difference was observed in the diameter of secondary 
follicles or their oocytes after treatment with control (n=46), 1M (n=28), 10M 
(n=50) or 100M (n=39) bpV (HOpic) (p>0.05) (see figure 5.22). No significant 
difference was observed in the diameter of secondary follicles or their oocytes after 
treatment with control (n=59), 0.1g/ml (n=43), 1g/ml (n=39), 10g/ml (n=36) or 











                                       














Figure 5.19: Images of Quiescent Follicles after Treatment with bpV 
(HOpic) and 740 Y-P. Images show the change in size of the quiescent follicles 
after treatment with 740 Y-P or bpV (HOpic). It is possible to see the A) quiescent 
follicles from the control group is smaller in comparison to those treated with B) bpV 

























   
                
 
 
Figure 5.21: Images of Primary Follicles after Treatment with bpV 
(HOpic) and 740 Y-P. Images display the enlargement of the primary follicles 
after treatment with bpV (HOpic) or 740 Y-P in comparison to the control. The a) 
control primary follicles are smaller in diameter than the b) bpV (HOpic) (1M) 
treated primary follicles (p<0.05) and c) 740 Y-P (0.1g/ml) primary treated follicles 















5.3.5 Examining the Diameters of the Healthy and Unhealthy Follicle 
Populations after Treatment with bpV (HOpic) and 740 Y-P  
 
 The diameter of the quiescent and primordial follicles was increased after 
treatment with both bpV (HOpic) and 740 Y-P, however, there was also a reduction 
in the proportion of healthy ovarian follicles within the cortical strips. The uncultured 
samples and control samples displayed no significant difference in the diameters of 
quiescent or primary follicles. The quiescent follicles within these two groups ranged 
from 20.25m to 30m in diameter, no significant difference was observed between 
the range of diameters of the healthy and unhealthy quiescent follicles within these 
two treatment groups. To explore if the change in the diameter of the quiescent 
follicles after treatment with bpV (HOpic) or 740 Y-P impacted the proportion of the 
healthy quiescent follicles, the quiescent follicles were divided into those within the 
control follicle diameter range of 20.25m to 30m and compared to those above 
this range. After treatment with bpV (HOpic) a significantly larger proportion of the 
healthy quiescent follicles were found within the control diameter range of 20.25m 
to 30m at 72.5±3.1%, 73.7±2.9% and 75.8±3.5% in 1M, 10M and 100M bpV 
(HOpic) (p<0.05) (see figure 5.23). Similarly, after treatment with 740 Y-P a 
significantly larger proportion of the healthy quiescent follicles were found within 
the diameter range of 20.25m to 30m at 68.8±3.6%, 69.3±3.7%, 73.6±3.5% and 
73.9±3.9% in 0.1g/ml, 1g/ml, 10g/ml and 100g/ml 740 Y-P respectively 
(p<0.05).  
Within the uncultured and control samples the primary follicles ranged from 
25.5m to 37m, no significant difference was observed between the diameters of 
the healthy and unhealthy primary follicle populations within these two treatment 
groups. To explore if the change in the diameter of the primary follicles impacted 
their health, the proportion of the healthy primary follicles were seperated into those 
within the control primary follicle diameter range of 25.5m to 37m compared to 
those above this range. After treatment with bpV (HOpic) a significantly larger 
proportion of the healthy primary follicle population was found within the control 
diameter range of 20.25m to 30m at 74.5±3.4%, 75.7±3.9% and 72.8±3.3% in 
1M, 10M and 100M bpV (HOpic) (n=24) (p<0.05) (see figure 5.24). Similarly, 
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after treatment with 740 Y-P a significantly larger proportion of the healthy primary 
follicles were found within the control diameter range of 20.25m to 30m at 
72.8±3.6%, 69.9±3.5%, 75.6±3.1% and 73.9±3.6% in 0.1g/ml, 1g/ml, 10g/ml 






















5.4 Discussion  
 
This study aimed to futher explore the role of the PI3K pathway in a large 
mono-ovulate species. To achieve this the two pharmological compounds 
bpV(HOpic) and 740 Y-P were utilised within an in vitro bovine model. When the 
PI3K pathway is stimulated, PI3K activates Akt through phosphorylation to mediate 
the downstream components of the pathway (Blume-Jensen and Hunter, 2001; 
Brunet et al., 2001; Cantley, 2002; Engelman et al., 2006; Stokoe, 2005; 
Vanderhyden, 2002). Within the in vitro bovine model there was shown to be an 
increase in the levels of p-Akt after bovine ovarian tissue fragments were treated 
with either bpV(HOpic) or 740 Y-P therefore, indicating both cause an up-regulation 
of the PI3K pathway. The data obtained within this study is comparible to previous 
studies as the up-regulation of the PI3K pathway in the bovine caused an increase in 
the activation of quiescent follicles similar to that observed in the knockout mouse 
models studies (Reddy et al., 2008, John et al., 2008, Castrillon et al., 2003, 
Rajareddy et al., 2007) and the mouse (Li et al. 2010) and the human (Li et al. 2010, 
McLaughlin et al., 2014) studies using these pharmacological compounds. Although, 
there was an increase in the proportion of activated primoridal follicles and therefore, 
an increase in the proportion of primary follicles the portion of secondary follicles 
was not increased after treatment with either bpv (HOpic) or 740 Y-P in comparison 
to the control.  
 In the previous study by Li et al., 2010 in the mouse model used a 
combination of 740 Y-P and bpV (HOpic) which resulted in an increase in the level 
of follicular activation compared to just bpV (HOpic) alone (Li et al, 2010) although, 
no significant change was seen between the combination of bpV (HOpic) and 740 Y-
P in comprison to 740 Y-P alone (Li et al., 2010). To examined if the level of PI3K 
stimulation impacted the level of activation of the primordial follicles in this study a 
range of concentrations of bpV (HOpic) or 740 Y-P were utilised, which has not 
been done in any previous study in the mouse or human. This study conveyed that 
different concentration of the both pharmological compounds did not impacted the 
percentage of quiescent follicles activated. Although, the various concentrations of 
740Y-P did display a non-significant trend towards an increase in activation with an 
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increase in the concentration of 740 Y-P, further investigation using a wider range of 
concentrations is required to confirm this trend. 
 Alongside the increase in primordial follicle activation in the bovine model, 
there was a decrease in follicular health in both the quiescent and primary follicle 
populations. The health of the quiescent follicles was not explored in the mouse 
models (Reddy et al., 2008, John et al., 2008, Castrillon et al., 2003, Rajareddy et al., 
2007, Li et al., 2010). The studies using the human model did explore the health of 
the follicle population and it was observed that there was a decrease in the health of 
larger isolated follicles after the initial activation of the quiescent follicles via the 
PI3K pathway (McLaughlin et al., 2014). Therefore, this study is the first to observe 
that these pharmacological compounds can impact not only the growing follicle 
population but also the quiescent follicle population. The level of health of the 
quiescent and primary follicle populations was reduced after treament with both bpV 
(HOpic) and 740 Y-P. The different concentrations of bpV (HOpic) and 740 Y-P 
displayed that the higher concentration of both compounds were more detrimental to 
the health of both the quiescent and primary follicle populations. Despite 740Y-P 
causing a greater increase in follicle activation it appears to have a less detrimental 
impact on the health of the quiescent and primary follicles in comparison to bpV 
(HOpic). This could be due to the different ways in which these pharmacological 
compounds stimulate the PI3K pathway. bpV (HOpic) is a PTEN inhibitor and 
causes an up-regulation of the PI3K pathway by binding to PTEN to prevent PIP3 
being converted back into PIP2 (Bevan et al., 1995; Posner et al., 1994; Schmidt et 
al., 2004). Whereas, 740 Y-P is a PI3K activator that up-regulates the PI3K pathway 
by binding to the p85 subunit of PI3K inhibiting its inhibition on p110, so p110 is in 
its high activate state (Derossi et al., 1998; Li et al., 2010). When Pten was knockout 
out in the granulosa cells there was a reduction in the number of apoptotic granulosa 
cells, but it did not cause an increase in the activation of the quiescent follicle 
population. Granulosa cells only contain a low level of Pten protein (Fan et al., 2008), 
and as bpV (HOpic) relies on the amount of Pten present this could prevent bpV 
(HOpic) stimulating the granulosa cell alongside the oocyte. Whereas, 740 Y-P 
might be able stimulate the PI3K pathway in the granulosa cells as it stimulates PI3K 
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itself, which could cause a reduction in the apoptotic granulosa cells in comparison 
to those treated bpV (HOpic) leading to healthier quiescent and primary follicles. 
 The decrease in the health of the primary follicles created via stimulation of 
the PI3K pathway is likely to be a key factor in there being no increase in the 
proportion of secondary follicles was observed as the quality of an ovarian follicle 
and its oocyte is a key factor in determining if the ovarian follicle will undergo 
atresia or continue through folliculogenesis (Blondin and Sirard, 1995; Hendriksen et 
al., 2004; Salamone et al., 1999). Therefore, the increase in degenerative primary 
follicles will mean that many of them are unable to progress to the secondary stage of 
follicular development. Alternatively, the secondary follicle may have required more 
time to develop from the primary follicle population as follicular development is 
known to be a protracted process (Adams and Pierson, 1995) and perhaps if left 
longer more secondary follicles would develop therefore, further investigation is 
required to better understand why the increase in primordial follicle activation does 
not result in an increase in the number of secondary follicles. 
The stimulation of the PI3K pathway way also caused an increase in the mean 
diameter of the quiescent and primary follicles. This increase in the diameter of the 
quiescent and primary follicles appears to be due to an enlargement of the oocytes 
within the follicle. Enlarged oocytes in the primary and quiescent follicles have been 
observed in previous mouse studies although not quantified (Castrillon et al., 2003; 
John et al., 2008; Reddy et al., 2008). This study shows that the increase in mean 
diameters of the quiescent and primary follicles is significant as well as showing 
similarities between the mouse and the bovine models. This is the first study to show 
that the PI3K pathway can cause this increase in oocyte diameter in a large mono-
ovulate species, as this has not been observed in the previous human studies (Li et al., 
2010, McLaughlin et al., 2014). The diameter of an oocyte is usually within a set 
range depending upon developmental stage that the ovarian follicles are within as 
described in the study Fair., 2003. In this study treatment with either bpV (HOpic) or 
740 Y-P resulted in the oocytes within the quiescent follicle population being similar 
in diameter to oocytes found in the primary follicles in the control group. Similarly, 
the primary follicles oocytes diameters were comparable to some of the oocytes 
within the secondary follicles within the control group. This enlargement of the 
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oocytes within the ovarian follicles suggests that there has been a disruption in the 
co-ordinated growth between an oocyte and its granulosa cells. The co-ordinated 
growth of an oocyte and its granulosa cells is essential in maintaining the health of an 
ovarian follicle (Cecconi et al., 2004; Hutt et al., 2006; Otsuka and Shimasaki, 2002; 
Wu et al., 2004) and a disruption within this could be a contributing factor to the 
poor health of the quiescent and primary follicles observed within this study. The 
PI3K pathway is thought to control the follicular activation via the oocyte as oocyte-
specific deletion of PTEN (Reddy et al., 2008) caused an increase in follicular 
activation, whereas granulosa cell-specific deletion of PTEN (Fan et al., 2008) had 
no impact on follicular activation. The lack of co-ordination after activation of the 
quiescent follicles through the PI3K pathway could be due to the PI3K pathway only 
driving the activation of the oocytes, but not the granulosa cells. However, further 
investigation is required to truly understand this disruption in the co-ordination 
growth of the oocyte and it’s granulosa cells.  
In summary manipulating the PI3K pathway causes an up-regulation of the 
activation of the primary follicles. However, up-regulating the PI3K pathway 
resulted in a dose-dependent decrease in the health of both the quiescent and primary 
follicle populations with increasing concentrations of both bpV (HOpic) and 740 Y-P. 
The PI3K pathway also impacted the regulation of ovarian follicle growth with the 
oocyte being enlarged in both the quiescent and primary follicle populations. This 
indicates a disruption in the communication between the oocyte and the granulosa 
cells although further investigation is required to better understand this. 
It has been proposed that these two pharmacological compounds are used in 
fertility treatments. A live human birth has recently been reported using bpV (HOpic) 
and 740 Y-P followed by replacement and IVF (Kawamura et al., 2013). However, 
the study did not have a control and the ovary was cut up which could have an 
impact on other pathways as well as the PI3K pathway so it is hard to determine if 
this was the result of the up–regulation of the PI3K pathway. The results in the 
present study displayed damage to the quiescent and primary follicles can be caused 
by these pharmacological compounds, indicating that we should be cautious as these 
results highlight these compounds have the potential to impact the health of not only 
the growing follicle populations, but also the quiescent follicle population. This 
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study shows that there was no increase in follicular activation despite an increase in 
concentration of the two compounds although, there is a decrease in the health with 
an increase in concentration of both therefore, it might be possible to find a 
concentration that causes the up-regulation of the PI3K pathway without the negative 
impact on the health of the quiescent and primary follicles. Further research is 
required to establish non-detrimental concentrations that can be safely used in 
clinical applications. 
The secondary follicle population had no increase in the population, health or 
follicle diameter despite the up-regulation of the PI3K pathway. However, the 
number of quiescent and primary follicles is very much higher than the number of 
secondary follicles in all treatment groups therefore, it is difficult to see the impact of 
the PI3K pathway on this later stage of development. To better understand if and 
how the later stages of follicle development are influence it would be beneficial to 
continue culturing the secondary population using the second part of the two-step 
culture system developed by the Telfer laboratory group (McLaughlin and Telfer, 
2010; Telfer et al., 2008).  This will determine if there is an increase in the number of 
large secondary follicles produced and the number of secondary follicles could then 
be further cultured to give a better indication of whether the number of mature 
oocytes obtained would be increased after increased primordial follicle activation via 
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The PI3K pathway has been shown to be important in primordial follicle 
activation, with the up-regulation of the PI3K pathway causing increased primordial 
follicle activation as observed in chapter 5 and previous studies in the mouse and 
human (Castrillon et al., 2003; John et al., 2008; Li et al., 2010; Liu et al., 2007; 
McLaughlin et al., 2014; Rajareddy et al., 2007; Reddy et al., 2009; Reddy et al., 
2008). Activation of the primordial follicles to become primary follicles is only the 
first step in the process of folliculogenesis, and is though to be the only step in which 
the PI3K pathway plays a role (Castrillon et al., 2003; John et al., 2008) (see figure 
6.1). However, activation is irreversible, so once a primordial follicle has been 
activated the primordial follicle must continue through the progressive stages of 
folliculogenesis or be lost through atresia (Elvin and Matzuk, 1998; Scaramuzzi et al., 
2011; Webb and Campbell, 2007; Webb et al., 2004). Although the PI3K pathway 
does not play a role in the subsequent steps of folliculogenesis, the increase in 
primordial follicles activation via the stimulation of the PI3K pathway does cause an 
increase in the number of primary follicles. Therefore, by up-regulating the PI3K 
pathway and increasing the number of primordial follicles that are activated will 
there be an increase in the number of mature oocytes produced?  
 
 
Figure 6.1: Folliculogenesis and the PI3K Pathway. The image displays the 
various stages of folliculogenesis needed for a mature oocyte to be produced from a 
primordial follicle. The PI3K pathway is only thought to play a role in the first stage 




 In chapter 5, activation of the quiescent follicles via the up-regulation of the 
PI3K pathway resulted in a decrease in the proportion of health primary follicles and 
altered primary follicles development. In the McLaughlin et al., 2014 study the up-
regulation of the PI3K pathway in the human resulted in a decrease in the survival of 
the secondary follicles (McLaughlin et al., 2014) therefore, it is important to further 
explore if activation via the PI3K pathway impacts the later stages of folliculogenesis.  
 To do this the quiescent follicle population was activated using bpV (HOpic) 
and 740 Y-P, as in chapter 5. After culturing the cortical strips the large secondary 
follicles were isolated and further cultured to observe the growth and number of large 
secondary follicles produced after increase follicular activation via the PI3K pathway. 
The in vitro culture system used in this study was developed by Telfer et al., 2008 
and McLaughlin and Telfer, 2010, in this system the quiescent follicles activated in 
the cortical strips must develop to reach a diameter of 100m before being isolated 
for the second step of the culture system. Only these follicles selected to be cultured 
further and eventually reach a stage where their oocytes could be extracted for 
maturation (McLaughlin and Telfer, 2010; Telfer et al., 2008). The number of large 
follicles obtained after treatment with bpV (HOpic) or 740 Y-P will therefore, 
indicate if the up-regulation of the PI3K pathway has the potential to increase the 
number of fertilisable mature oocytes produced. This chapter also aimed to examine 
the development and health of each isolated secondary follicles during their culture 













6.2 Materials and Methods 
 
6.2.1 Bovine Tissue Culture 
 
 Bovine ovaries were collected from a local abattoir from animals aged 
between 10-14 months and transported to the laboratory in supplemented M199 
medium. Strips of the cortex were removed from the ovaries to a depth of 1-2mm 
(see figure 6.2). The strips were examined under a light microscope in bovine 
Leibovitz medium to ensure that all the ovarian follicles within them were less than 
40μm in diameter. These cortical strips were further dissected to approximately 0.5-1 
mm2 in size. The cortical strips were treated with bovine McCoy’s or bovine 
McCoy’s with 1µM, 10µM or 100µM of bpV (HOpic) or 0.1µg/ml, 1µg/ml, 10µg/ml 
or 100µg/ml of 740 Y-P in a humidified incubator at 37°C with 5% CO2 for 24 hours. 
After 24 hours all the medium was removed and replaced with bovine McCoy’s 
medium only for a further 6 days, with a medium change every 48 hours (as 
described in chapter 2). 
 The cortical strips were then placed in bovine Leibovitz medium and 
examined under a light microscope with a heated plate set to 37°C to maintain 
temperature in a lamina flow hood. Every follicle that was 100µm in diameter or 
above was dissected out of the cortical strips using 25 gauge needles (Terumo 
Europe, Belgium) attached to a 1 ml syringe barrels (BD Plastipak, Becton 
Dickinson and Company, Madrid, Spain), ensuring as much stromal tissue was 
removed from around the ovarian follicle as possible without damaging it. The 
ovarian follicles were then cultured individually for a further 6 day in a humidified 
incubator at 37°C with 5% CO2 in 96 well v-bottomed plates (Corning Co-star 
Europe, Badhoevedorp, The Netherlands), with one follicle per each well in 150µl 
bovine McCoy’s medium with the addition of 100ng/ml recombinant human Activin 
A (R&D Systems, Abingdon, UK). The medium was changed every 48 hours by 
removing 75µl from the well and replacing it with 75µl of fresh bovine McCoy’s 
medium with recombinant human Activin A.  
The diameter of each follicle was measured immediately after dissection 
using a light microscope and then every 48 hours alongside the medium changes, at 
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were healthy. If these criteria were met the ovarian follicle was classified as healthy, 
and if not they were deemed unhealthy. 
  
6.2.3 Statistical Analysis 
 
The Kolmogorov Smirnoff test was used to test for normal distribution; 
further statistical tests were chosen based on whether the data was normal distributed 
or not. The bovine culture was repeated 7 times for the different treatments of both 
bpV (HOpic) and 740 Y-P. The proportion of the follicles collected from cultured 
cortical strips from the different treatment groups was compared using a chi-square 
test (n=7). The diameter of the isolated follicle at dissection and during the further 6 
days of culture was compared between the control with the various concentrations of 
bpV (HOpic) or with the various concentrations of 740 Y-P using a one-way 
ANOVA, where this test reported a significant difference the groups were compared 
individually using a post hoc Tukey test. The health of the isolated follicles was 
compared using a chi-square test (n=7). The comparison of change in follicle size 
after treatments with various amounts of either bpV (HOpic) or 740 Y-P were 
compared to the control using a two-way ANOVA, where this test reported a 
significant difference the groups were compared individually using a post hoc Tukey 




6.3.1 The Proportion of Isolated Follicles Collected After Treatment with 
bpV (HOpic) or 740 Y-P. 
 
 Table 6.1 displays the number of secondary follicles obtained from each 
treatment group. Figure 6.3 shows the proportion of follicles obtained from each 
treatment group from the total number of follicles obtained in each experiment. The 
proportion of isolated follicles collected from the different treatment groups were 
compared against one another. No significant difference was observed in the 
proportion of isolated follicles collected from the control or bpV (HOpic) treatment 
groups with 37.83.0%, 18.84.1% and 15.6 4.8% isolated from 1M, 10M and 
100M of bpV (HOpic) compared to 27.84.5% collected from the control (n=7) 
(p>0.05) (see figure 6.3 A). No significant difference was seen in the proportion of 
isolated follicles collected from the 740 Y-P treatment groups at 18.43.7%, 
20.73.5%, 27.43.5% and 15.34.5% of the isolated follicles collected from 
0.1g/ml, 1g/ml, 10g/ml and 100g/ml 740 Y-P respectively compared to 
18.23.2% in the control (n=17) (p>0.05) (see figure 6.3 B). 
 


























Figure 6.3: Proportion of Follicles Isolated from the Different Treatment 
Groups. These graphs display the proportion of large ovarian follicles isolated from 
the control group compared to either the A) bpV (HOpic) treatment groups or the b) 
740 Y-P treatment groups. No significant difference was observed in the number of 
large follicles isolated from the control group in comparison to the a) bpV (HOpic) 
(p>0.05) treatment groups or the B) 740 Y-P treatment groups (p>0.05). 
A)   
B)   
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6.3.2 The Diameters of the Isolated Follicles after Treatment with bpV 
(HOpic) or 740 Y-P. 
 
 The diameters of the large ovarian follicles isolated from the cortical strips 
were measured directly after isolation prior to further culturing in the second step of 
the two-step culture system. No significant difference was observed between the 
mean diameter of the follicles isolated from the control (n=18) at 104.8m 3.8 and 
those treated with bpV (HOpic) which had mean diameters of 107.3m 3.2, 
109.5m 3.9 and 104.3m 5.0 in 1M (n=24), 10M (n=15) and 100M (n=12) 
of bpV (HOpic) (p>0.05) (see figure 6.4 A). No significant difference was observed 
in the mean follicle diameters of the follicles treated with 740 Y-P at 100.4m 4.4, 
101.8m 4.6, 109.5m 3.4, 107.5m 3.4 in 0.1g/ml (n=16), 1g/ml (n=18), 
10g/ml (n=22) and 100g/ml (n=15) 740 Y-P compared to the control (n=17) at 





Figure 6.4: Mean Diameter of Large Ovarian Follicles at Isolation from the 
Different Treatment Groups. These graphs display the mean diameter of the 
ovarian follicles immediately after they were isolated after treatment with the control 
compared to either A) bpV (HOpic) or B) 740 Y-P. No significant difference was 
seen in the mean diameter of the isolate ovarian follicles after treatment with either 
bpV (HOpic) (p>0.05) or 740 Y-P (p>0.05). 
A)   
B)   
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6.3.3 The Mean Diameter of the Follicle in Culture after Treatment with 
bpV (HOpic) or 740 Y-P. 
 
 The diameters of the large ovarian follicles isolated from the cortical strips 
were measured at regular intervals during the second step of the two-step culture 
system. No significant difference was observed in the mean diameters of the isolated 
follicles during this culture period with either the various concentrations of bpV 
(HOpic) (p>0.05) or 740 Y-P (p>0.05) in comparison to the control at any time point 
(see figure 6.5). Although there was seen to be no significant difference in the 
change in follicle diameter over time both treatments with bpV (HOpic) and 740 Y-P 
displayed a non-significant trend towards the growth of the ovarian follicles 
stimulated with the higher concentrations having a lower growth rate with ANOVA 






Figure 6.5: Mean Diameter of the Isolated Ovarian Follicles in Culture 
from the Different Treatments. These graphs show the change in the mean 
diameter of the isolated follicles during in the culture period in the control compared 
with A) bpV (HOpic) and B) 740 Y-P. Neither bpV (HOpic) (p>0.05) nor 740 Y-P 
(p>0.05), displayed a significant difference in mean follicle diameter during in the 
culture period.  
A)   
B)   
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6.3.4 The Follicular Health of the Isolated Follicles after Treatment with 
bpV (HOpic) or 740 Y-P. 
 
 The health of the isolated ovarian follicles was examined at the end of the 
culture period. The health of the isolated follicles that has been treated with bpV 
(HOpic) displayed no significant difference in health at 51.0±4.8%, 48.7±4.3%, 
46.0±6.4% in 1M, 10M and 100M of bpV (HOpic) compared to the control at 
54.3±4.0% (n=7) (p>0.05) (see figure 6.6 A). Similarly, no significant difference was 
observed in the health of the isolated follicles after treatment with 740 Y-P at 
52.2±3.8%, 54.8±3.84%, 50.7±4.9%, 48.6±4.3% 0.1g/ml, 1g/ml, 10g/ml and 
100g/ml in comparison to 55.5±3.7% in the control (see figure 6.6 B). Although 
there is no significant difference there is a trend towards an increase in the 
concentration of with both bpV (HOpic) and 740 Y-P resulting in a decrease in the 







Figure 6.6 Proportion of Healthy of Ovarian Follicles. These graphs display 
the proportion of healthy ovarian follicles after culture with A) bpV (HOpic) or B) 
740 Y-P in comparison to the control. No significant difference was observed in the 
proportion of ovarian follicles after treatment with the control in comparison to bpV 
(HOpic) (n=7) (p>0.05) or 740 Y-P (n=7) (p>0.05). 
A)   





The aim of this study was to further examine if the increased primordial 
follicle activation via the PI3K pathway had any impact on the later stages of 
folliculogenesis. This was achieved by using the pharmacological compounds bpV 
(HOpic) and 740 Y-P in an in vitro bovine model, using the two step culture system 
developed by Telfer et al., 2008 and McLaughlin and Telfer, 2010, to stimulate the 
PI3K pathway and cause an increase in primordial follicle activation and then 
examine the follicles development at the secondary stage of folliculogenesis. The 
results display that the number of large follicles obtained did not change after 
treatment with either bpV (HOpic) or 740 Y-P. The results also showed that 
development and the health of the secondary follicles by the initial treatment with 
bpV (HOpic) or 740 Y-P was the same as those from the control group. 
The PI3K pathway has been shown to play an important role in controlling 
primordial follicle activation (Castrillon et al., 2003; John et al., 2008; Li et al., 2010; 
Liu et al., 2007; McLaughlin et al., 2014; Rajareddy et al., 2007; Reddy et al., 2009; 
Reddy et al., 2008), with the up-regulation of the PI3K pathway causing increased 
activation. Chapter 5 showed that an up-regulation of the PI3K pathway caused 
increase follicle activation and therefore, an increased proportion of primary follicles.  
Despite this increase in activation there was no significant increase observed in the 
number of large ovarian follicles obtained after treatment with either bpV (HOpic) or 
740 Y-P. This result differs from previous mouse and the human studies where there 
was an increase in the number of further developed follicles (Castrillon et al., 2003; 
Li et al., 2010; McLaughlin et al., 2014; Rajareddy et al., 2007; Reddy et al., 2008). 
It is possible that the secondary follicles need more time to develop from the primary 
follicle population as follicular development is known to be a protracted process 
(Adams and Pierson, 1995) and perhaps if the cortical strips had been cultured for a 
longer period more secondary follicles would have develop. However, there are other 
factors that could be influencing the proportion of secondary follicles produced. 
One factor influencing the number of large ovarian follicles obtained after 
treatment with bpV (HOpic) or 740 Y-P could be the due to the observed decrease in 
the health of the primary follicle population seen in chapter 5. The quality of an 
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ovarian follicle and its oocyte is a key factor in determining if an ovarian follicle will 
continue through folliculogenesis (Blondin and Sirard, 1995; Hendriksen et al., 2004; 
Salamone et al., 1999). With the dramatic decrease in the health of the primary 
follicles seen in the chapter 5, it is possible to hypothesis that the increase in 
degenerative primary follicles will result in many of the follicles undergoing atresia 
at the primary follicle stage rather than continuing to develop through the progressive 
stages of folliculogenesis. 
Despite the fact there is seen to be an increase in the number of primordial 
follicles being activated there was no observed increase in the proportion of 
secondary follicles in chapter 5 or large follicle in chapter 6. The decrease in the 
morphological health of the secondary follicles in study by McLaughlin et al., 2014 
in the human and a trend towards a decrease in secondary follicles health observed 
within this thesis, indicates that there would not be an increase in the number of 
mature oocytes produced. Therefore, this chapter and previous study indicate that up-
regulating activation via the PI3K pathway does not necessarily cause an increase in 
the number of mature oocyte obtained. Primordial follicles are activated in small 
cohorts that decrease in number as they progress through the various stages of 
folliculogenesis due to loss by atresia (Fortune, 1994; Macklon and Fauser, 1999 
Morbeck et al., 1992). Only a set number of primary follicles develop into secondary 
follicles to control and ensure the correct number of dominant follicles are produced 
dependent on the species therefore, only allowing a controlled number of primary 
follicles to reach the secondary stage of follicle development. 
 The ovarian follicles isolated at day 6 were similar in diameter in each 
treatment group to the control group, despite chapter 5 showing that the up-
regulation of the PI3K pathway causing an increase in the diameter of the primary 
follicles. The results from chapter 5 conveyed that the enlargement of the ovarian 
follicles was seen to coincide with a decrease in the health of the follicles, which is 
thought to be due to a disruption in the communication between the oocyte and its 
granulosa cells, which is essential to maintain the health of the ovarian follicles 
(Elvin et al., 2000; Fair, 2010; Moor, 1988; Nagyova et al., 2000; Rodgers et al., 
2000; van den Hurk and Zhao, 2005). Therefore, it is likely that many of the primary 
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follicles were unable to develop to the later stages of folliculogenesis due to this 
increase in the proportion that became degenerative. 
In summary, the PI3K pathway in the bovine model has only been observed 
in this these to impact the development of the ovarian follicles at the activation of the 
quiescent to primary follicles stage of development, but not later stages of follicular 
developmental. The results of this thesis confirms the results of the previous studies 
by Castrillon et al., 2003 and John et al., 2007 in the mouse model that also showed 
that the role of the PI3K pathway in folliculogenesis is limited to the early stages of 
folliculogenesis (Castrillon et al., 2003; John et al., 2007). The role of the PI3K 
pathway in folliculogenesis is restricted to the first stage of folliculogenesis as its key 
downstream components, Foxo3a and p27, are only active in the nucleus where they 
inhibit the quiescent follicles development. When the PI3K pathway is stimulated 
these components are exported into the cytoplasm where they are degraded allowing 
quiescent follicles to become primary follicles (Blume-Jensen and Hunter, 2001; 
Brunet et al., 2001; Cantley, 2002; Engelman et al., 2006; Stokoe, 2005; 
Vanderhyden, 2002, Accili and Arden, 2004; Arden and Biggs, 2002; Liu et al., 2007, 
Fero et al., 1996; Rajareddy et al., 2007; Zhang et al., 1999). The degradation of 
these key components after activation means that they will be unable to influence the 
later stages of follicular growth as observed in this study. Therefore, although the 
PI3K pathway is known to play an important role in cellular growth (Cantley, 2002; 
Stokoe, 2005) this role is limited to the activation of the quiescent follicles into 
primary follicles and does not impact the growth of the large isolated ovarian 
follicles cultured within this chapter. Subsequently, there was no increase in the 
number or growth of these large ovarian follicles this chapter indicating that the 
increase in activation of the quiescent follicles via the PI3K pathway does not cause 
an increase in the number of secondary follicles and therefore, it is unlikely that more 































7.1 General Discussion 
 
 It is widely accepted that in most mammalian species the only source of 
oocytes that have the potential to mature and be fertilised is produced in fetal or early 
life, with no additional primordial follicles being created at any other point during 
the female’s life (McGee and Hsueh, 2000; Zuckerman, 1951). Oocytes are held in 
an immature state in primordial follicles (Escobar et al., 2011; McGee and Hsueh, 
2000). In order for a mature oocyte to be produced the primordial follicles must be 
activated to undergo folliculogenesis (Binelli and Murphy, 2010; McGee and Hsueh, 
2000). There is still much we do not know about quiescent follicle activation, and 
although there is evidence of a number of different factors that are known to play a 
role, the mechanisms involved are still unclear (Adhikari et al., 2013; Kim, 2012; 
Monget et al., 2012; Pangas, 2012; Reddy et al., 2010). The PI3K pathway has been 
shown to be a key factor in the activation of primordial follicles (Castrillon et al., 
2003; John et al., 2008; Li et al., 2010; Liu et al., 2007; McLaughlin et al., 2014; 
Rajareddy et al., 2007; Reddy et al., 2009; Reddy et al., 2008). However, the role of 
the PI3K pathway has been primarily explored in the rodent model therefore, it is 
important to explore its role in other species to see if it has the same central role.  
 The main aims of this thesis were to therefore; (1) to explore if an increase in 
the stimulation of the PI3K pathway impacts primordial follicle activation, health 
and subsequent growth in the bovine model. (2) Examine if increased stimulation of 
the PI3K pathway caused any changes in the development of the activated follicles. 
It was also important to (3) explore the location and distribution of the ovarian 
follicle populations, including the primordial follicles, within the ovary and to 
examine if their location within the ovary had any influenced on health of the ovarian 
follicle populations. Lastly, to (4) examine if the bovine is a good model of human 
primordial follicle activation and subsequent growth within an in vitro culture system. 
The ovary consists of three main components; the surface epithelium, the 
cortex and the medulla (Escobar et al., 2011). Analysis of the bovine ovarian follicle 
populations (chapter three) and other studies showed that the ovarian follicle 
population is concentrated in the cortex of the ovary. The distribution of the different 
developmental stages of the ovarian follicles was different within different regions of 
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the ovary. The quiescent follicles population was concentrated in the outer region of 
the ovary whereas, a larger proportion of the ovarian follicle populations were 
growing follicles in the progressively deeper regions of the ovary (Jimenez, 2010; 
vanWezel and Rodgers, 1996). This change in the distribution of the different 
developmental stages of the ovarian follicles in the different regions of the ovary 
could be due to the timing of ovarian follicle formation. The first primordial follicles 
are formed in the medulla and they are thought to be the first to be activated and 
therefore, first to be lost (Henderson and Edwards, 1968; Hirshfield, 1991; Mork et 
al., 2012). A previous study in the mouse indicated that the timing of follicle 
formation influenced the ability of the ovarian follicles to maintain their dormancy, 
due to the progenitors not having fully developed in those formed earlier (Mork et al. 
2012). The lower concentration of ovarian follicles in the medulla and cortex-
medulla of bovine and human could be an indication that something similar happens 
in these two species, although further investigation is required to establish this. The 
line hypothesis (Henderson and Edwards, 1968), the progenitor’s development 
(Mork et al. 2012) and the Kristensen et al., 2010 study all indicate that age is a key 
factor to the presence of primordial follicles within the medulla. One criticism of the 
present study is that a wider variety of ages should have been used, as it would have 
given a better insight to what happens to the ovarian follicles within the medulla. It is 
possible to speculate that ovarian follicles were found in the medulla of the bovine 
and not in the human in this study, because the bovine ovarian tissue samples were 
from comparatively younger animal than the human ovarian tissue samples.  
The observed decrease in health of follicles located in the cortex and medulla 
could also have contributed to the lower concentration of ovarian follicles in the 
inner regions of the ovaries. This decrease in health appears to be due to the different 
environments surrounding the ovarian follicles, as there was no difference in the 
health of the ovarian follicles from the outer cortex and inner cortex in the bovine 
model. This decrease in health could be due to the concentration of the stromal cells 
surrounding the ovarian follicles, as cortex of the ovary that has a higher 
concentration of stromal cells had proportionally more healthy follicles compared to 
the cortex-medulla and medulla where the stromal cells are less concentrated. The 
role of the stromal cells in maintaining the health of ovarian follicles is unclear 
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however, the stroma is known to induce differentiation of the theca cells, which does 
not occur with medullary stromal cells (Orisaka et al., 2006) indicating that they are 
required in the process of folliculogenesis. However, further investigation is required 
to understand the role of the stromal cells in preserving follicular health. It would be 
interesting to examine if stromal environment required is different at the various 
stage of follicular development, as growing follicles are though to migrate from the 
outer cortex to the inner regions of the ovary (Woodruff and Shea, 2011). The data 
from the present study showed that the reduction in the distribution and health of the 
quiescent follicles in the inner regions of the ovary makes the cortex region a more 
favourable region to use for culture in functional studies exploring the quiescent 
follicle population and therefore, was the region utilised in the later experiments on 
the role of the PI3K pathway in primordial follicles activation.  
 The role of the PI3K pathway in this thesis was explored in the bovine. The 
bovine has similar attributes to the human in folliculogenesis (Adams and Pierson, 
1995; Baerwald, 2009; Gougeon, 1996) making it a good candidate for this study as 
it would not only show the role of the PI3K pathway in the bovine, but also give a 
good indication of role of the PI3K pathway in the human. The rate of follicle 
activation and development was compared between the bovine and the human in an 
in vitro culture system (chapter 4). It was observed that the human and the bovine 
had similar levels of activation with a similar percentage of ovarian follicles 
becoming primary and secondary follicles. The level of growth in the transition 
between a quiescent follicle and a primary follicle was also shown to be similar in 
the two species. These similar attributes indicate that the bovine is a good model for 
primordial follicle activation in vitro for the human. For future studies it would be 
beneficial to further compare the bovine and human follicular development to 
include the later stages of folliculogenesis in vitro to see if the bovine model 
continues to be a good model for the human in later stages of folliculogenesis, as it 
would be useful to have a model that is similar to the human throughout the entire 
process of folliculogenesis.  
The up-regulation of the PI3K pathway in the bovine model was shown to 
cause an increase in primordial follicle activation (chapter 5), agreeing with previous 
studies in the mouse (Castrillon et al., 2003; John et al., 2008; Li et al., 2010; Liu et 
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al., 2007; McLaughlin et al., 2014; Rajareddy et al., 2007; Reddy et al., 2009; Reddy 
et al., 2008). Interestingly the different concentrations of bpV (HOpic) and 740 Y-P 
did not result in different levels of activation, though it was shown to impact the 
health of the quiescent and primary follicle populations. However, it is possible to 
speculate that perhaps there is an upper limit on the number of quiescent follicles that 
can be activated at one time, which could be causing the decrease in the number of 
health quiescent and primary follicles. It is possible to hypothesis that utilisation of 
lower levels of stimulation of the PI3K pathway could have revealed that the level of 
activation of quiescent follicle is dose-dependent however, further investigation is 
required to explore this theory.  
The PI3K pathway is known to play an important role in cellular growth 
(Cantley, 2002; Stokoe, 2005) and is seen to influence the growth of the oocytes, 
which become enlarged in the primary and quiescent follicles when the PI3K 
pathway is up regulated (chapter 5) agreeing with previous studies (Castrillon et al., 
2003; John et al., 2008; Reddy et al., 2008). The enlargement of oocytes suggests 
that the communication between the oocyte and its granulosa cells has been disrupted, 
which is particularly highlighted in the quiescent follicles where there are enlarged 
oocyte indicated that the oocyte has been activated to grow but the granulosa cells do 
not appear to have been stimulated to begin to proliferating, creating a population of 
activated transitory follicles. A lack of communication between the oocyte and its 
granulosa cells could be a key factor causing a reduction in the health of the bpV 
(HOpic) and 740 Y-P treated ovarian follicles, which must be balanced for the 
ovarian follicle to remain healthy (Elvin et al., 2000; Fair, 2010; Moor, 1988; 
Nagyova et al., 2000; Rodgers et al., 2000; van den Hurk and Zhao, 2005). Enlarged 
oocytes in the primary and quiescent follicles were observed in previous mouse 
studies (Castrillon et al., 2003; John et al., 2008; Reddy et al., 2008). Primary and 
quiescent follicle containing these enlarged oocytes did not appear to be able to 
progress to the later stages of folliculogenesis and eventually degenerated. The 
importance of maintaining balanced development between an oocyte and its ovarian 
follicle is highlighted in this thesis by a lower proportion of the healthy ovarian 
follicles being observed in the follicle diameters above the range seen in the control 
ovarian follicles (chapter 5). This imbalance of development between the oocyte and 
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its granulosa cells maybe because the PI3K pathway has a bigger influence on the 
development of the oocyte than the granulosa cells, indicated by oocyte-specific 
deletion of PTEN (Reddy et al., 2008) causing increased follicular activation, 
whereas, granulosa cell-specific deletion of PTEN (Fan et al., 2008) had no impact 
on the level of follicular activation.  
 Despite the increase in activation and therefore, increase in the number of 
primary follicles, the secondary follicle population was not seen to increase (chapter 
5). Neither was there a significant increase in the number of large secondary follicles 
that were isolated during the second step of the two-step culture system after 
increased quiescent follicle activation via the up-regulation of the PI3K pathway 
(chapter 6). This lack of further developed ovarian follicles could be due to the 
decrease in proportion of healthy primary follicle seen in chapter 5, as the quality of 
the ovarian follicle is key in determining whether it will continue through 
folliculogenesis or undergo atresia (Blondin and Sirard, 1995; Hendriksen et al., 
2004; Salamone et al., 1999). Therefore, the high level of degeneration exhibited in 
the primary follicle after treatment with bpV (HOpic) and 740 Y-P will mean that 
many of the primary follicles would have been unable to progress further in their 
development. However, the ovarian follicles that were able to progress to the later 
stages of folliculogenesis were seen to be similar in size and health to the control 
follicles when isolated at day 6 (chapter 6). 
These results differ from the previous human study in vitro where the up-
regulation of the PI3K pathway had no impact on the growth of either the quiescent 
or primary follicle populations and consequently the increase in activation resulted in 
an increase in the number of secondary follicle obtained (Li et al., 2010; McLaughlin 
et al., 2014). The difference between this thesis and the previous studies may be 
related to the comparative ages at which the ovarian samples were taken, as the 
bovine material has been derived from younger individuals and so has a high 
concentration of ovarian follicles, (McGee and Hsueh, 2000) as seen in chapter 4. 
This means that there was a larger number of quiescent follicles being activated in 
the bovine and consequently this will have cause more inhibitory factors to be 
produced as there are more growing follicle, which would inhibit follicle activation 
and growth of other ovarian follicles (Edwards et al., 1977; McGee and Hsueh, 2000). 
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This may be why the quiescent and primary follicles populations are seen to have a 
proportion decrease in health in the bovine model from younger tissue samples in 
chapter 5 in comparison to the human with older tissue sample utilised in the 
previous studies. The results presented in chapters 5 and 6 are most likely to be a 
good indication of what would occur in a younger human ovary. Despite this 
differences between the bovine and human the in vitro culture systems both display a 
decrease in the survival of the ovarian follicles after increased activation via the 
PI3K pathway, so there is little chance of more mature fertilisable oocytes being 
produced thorough increased stimulation of the PI3K pathway. 
 
7.2 Concluding Remarks 
 
This thesis aimed to explore the role of the PI3K pathway in a large mono-
ovulatory species, using an in vitro bovine model. The up-regulation of the PI3K 
pathway was shown to cause an increase in the activation of the ovarian follicles. 
This thesis also identified that up-regulation of the PI3K pathway caused a decrease 
in the health of both the quiescent and primary follicle populations. This decrease in 
health was dose-dependent, with higher doses of bpV (HOpic) and 740 Y-P causing 
increased degeneration in the ovarian follicle populations. The up-regulation of the 
PI3K pathway resulted in the enlargement of the oocytes in the quiescent and 
primary follicles, which could be a contributing factor to the increased degeneration 
in the primary and quiescent follicle populations. As a result there was no significant 
increase in the number of further developed ovarian follicles and therefore, it is 
unlikely that more fertilisable oocytes would have been produced.  
 Recently, a live human birth has been reported using bpV (HOpic) and 740 
Y-P treatments of ovarian fragments in vitro, followed by replacement and IVF 
(Kawamura et al., 2013). However, the study did not have a control and the ovary 
was cut up which could have an impact on other pathways as well as the PI3K 
pathway so it is hard to determine if this was due to the stimulation of the PI3K 
pathway. Chapter 5 showed that the utilisation of these pharmacological compounds 
in the bovine model resulted in a decrease in the health of not only the growing 
follicle populations, but also the quiescent follicle population. Chapter 5 also showed 
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there was no increase in follicular activation despite an increase in concentration of 
both bpV (HOpic) and 740 Y-P, although there is a decrease in the health with an 
increase in concentration. Therefore, it might be possible to find a concentration that 
causes the up-regulation of the PI3K pathway without causing a decreased in the 
health of the follicles. Further research is required to establish non-detrimental 
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